Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	G protein-coupled glutamate receptor activity	GRM3 GRM4 GRM5 GRM7	1.26e-06	9	203	4	GO:0098988
GeneOntologyMolecularFunction	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity	GRM3 GRM4 GRM5 GRM7	1.26e-06	9	203	4	GO:0001640
GeneOntologyMolecularFunction	microfilament motor activity	MYH6 MYO1A MYO7B MYO9A MYO5C MYO1B	2.16e-06	38	203	6	GO:0000146
GeneOntologyMolecularFunction	calcium channel activity	TRPC4 TRPC5 RYR3 CACNA1F PKD2L1 PKD1L3 GRM7 CACNA2D4 PKD2L2	6.95e-06	129	203	9	GO:0005262
GeneOntologyMolecularFunction	actin filament binding	MYH6 ABL1 MYO1A MYO7B MYO9A MYO5C TLN2 FLII MYO1B CTNNA3 CTNNA1	2.19e-05	227	203	11	GO:0051015
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	TRPC4 TRPC5 RYR3 CACNA1F PKD2L1 PKD1L3 GRM7 CACNA2D4 PKD2L2	2.47e-05	151	203	9	GO:0015085
GeneOntologyMolecularFunction	channel activity	PIEZO1 TRPC4 TRPC5 CHRM5 RYR3 KCNMB1 KCNN1 CACNA1F PKD2L1 ABCC9 PKD1L3 GRM7 CACNA2D4 PKD2L2 CLCA2 SLC14A1 SLC12A7	2.79e-05	525	203	17	GO:0015267
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH6 MYO1A MYO7B MYO9A MYO5C STARD9 DNAH3 MYO1B	2.80e-05	118	203	8	GO:0003774
GeneOntologyMolecularFunction	passive transmembrane transporter activity	PIEZO1 TRPC4 TRPC5 CHRM5 RYR3 KCNMB1 KCNN1 CACNA1F PKD2L1 ABCC9 PKD1L3 GRM7 CACNA2D4 PKD2L2 CLCA2 SLC14A1 SLC12A7	2.85e-05	526	203	17	GO:0022803
GeneOntologyMolecularFunction	actin binding	MYH6 ABL1 MYO1A MYO7B MYO9A TRPC5 GBP3 ACE MYO5C SYNE2 TLN2 DNASE1 FLII MYO1B CTNNA3 CTNNA1	3.33e-05	479	203	16	GO:0003779
GeneOntologyMolecularFunction	monoatomic cation channel activity	PIEZO1 TRPC4 TRPC5 RYR3 KCNMB1 KCNN1 CACNA1F PKD2L1 ABCC9 PKD1L3 GRM7 CACNA2D4 PKD2L2	5.22e-05	343	203	13	GO:0005261
GeneOntologyMolecularFunction	ATP-dependent activity	MYH6 MYO1A MYO7B MYO9A MYO5C STARD9 SHPRH ABCC2 DNAH3 SMCHD1 WRN ABCC9 MYO1B UBA3 HELQ CHTF18 ATP1A4 SNRNP200	5.90e-05	614	203	18	GO:0140657
GeneOntologyMolecularFunction	monoatomic ion channel activity	PIEZO1 TRPC4 TRPC5 CHRM5 RYR3 KCNMB1 KCNN1 CACNA1F PKD2L1 ABCC9 PKD1L3 GRM7 CACNA2D4 PKD2L2 CLCA2	7.53e-05	459	203	15	GO:0005216
GeneOntologyMolecularFunction	vascular endothelial growth factor receptor 3 binding	VEGFD VEGFC	1.03e-04	2	203	2	GO:0043185
GeneOntologyMolecularFunction	sour taste receptor activity	PKD2L1 PKD1L3	1.03e-04	2	203	2	GO:0033040
GeneOntologyMolecularFunction	calmodulin binding	MYH6 MYO1A ACE RYR3 MYO5C KCNN1 MYO1B GRM4 GRM7 RGS2	1.28e-04	230	203	10	GO:0005516
GeneOntologyMolecularFunction	glutamate receptor activity	GRM3 GRM4 GRM5 GRM7	1.52e-04	27	203	4	GO:0008066
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	TRPC4 TRPC5 CHRM5 RYR3 KCNMB1 KCNN1 ABCC2 CACNA1F PKD2L1 ABCC9 PKD1L3 GRM7 CACNA2D4 PKD2L2 CLCA2 SLC14A1 SLC15A1 ATP1A4 SLC12A7	2.80e-04	758	203	19	GO:0015318
GeneOntologyMolecularFunction	transporter activity	SLCO2B1 SLC35C1 PIEZO1 TRPC4 TRPC5 CHRM5 RYR3 KCNMB1 KCNN1 ABCC2 VMP1 CACNA1F CYB561D2 PKD2L1 ABCC9 APOB PKD1L3 GRM7 SLC2A3 CACNA2D4 PKD2L2 CLCA2 SLC14A1 SLC15A1 SLCO2A1 ATP1A4 SLC12A7	2.82e-04	1289	203	27	GO:0005215
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	TRPC4 TRPC5 RYR3 KCNMB1 KCNN1 CACNA1F PKD2L1 ABCC9 PKD1L3 GRM7 CACNA2D4 PKD2L2 ATP1A4 SLC12A7	3.04e-04	465	203	14	GO:0046873
GeneOntologyMolecularFunction	calcium-activated potassium channel activity	KCNMB1 KCNN1 PKD2L1	3.47e-04	14	203	3	GO:0015269
GeneOntologyMolecularFunction	transmembrane transporter activity	SLCO2B1 SLC35C1 PIEZO1 TRPC4 TRPC5 CHRM5 RYR3 KCNMB1 KCNN1 ABCC2 CACNA1F CYB561D2 PKD2L1 ABCC9 PKD1L3 GRM7 SLC2A3 CACNA2D4 PKD2L2 CLCA2 SLC14A1 SLC15A1 SLCO2A1 ATP1A4 SLC12A7	4.07e-04	1180	203	25	GO:0022857
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	MYH6 PDE8A INPP4A BCHE FBP2 ACOT4 CHRM1 CHRM5 CCR1 DNASE1 LRRC18 DUSP6 WRN PLPP2 ACOT11 PAN3 RNASEH1 CNOT1 CPSF3	6.03e-04	807	203	19	GO:0016788
GeneOntologyMolecularFunction	adenylate cyclase inhibitor activity	GRM7 RGS2	6.09e-04	4	203	2	GO:0010855
GeneOntologyMolecularFunction	group III metabotropic glutamate receptor activity	GRM4 GRM7	6.09e-04	4	203	2	GO:0001642
GeneOntologyMolecularFunction	gated channel activity	PIEZO1 CHRM5 RYR3 KCNMB1 KCNN1 CACNA1F PKD2L1 ABCC9 GRM7 CACNA2D4 CLCA2	6.47e-04	334	203	11	GO:0022836
GeneOntologyMolecularFunction	cyclase inhibitor activity	GRM7 RGS2	1.01e-03	5	203	2	GO:0010852
GeneOntologyMolecularFunction	GTPase binding	KNTC1 RIN2 HACE1 RAB29 DOCK2 IPO7 STRIP1 EXOC8 EXOC5 RADIL PKN2	1.19e-03	360	203	11	GO:0051020
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	PIEZO1 TRPC4 TRPC5 CHRM5 RYR3 KCNMB1 KCNN1 CACNA1F PKD2L1 ABCC9 PKD1L3 GRM7 CACNA2D4 PKD2L2 CLCA2 SLC15A1 ATP1A4 SLC12A7	1.27e-03	793	203	18	GO:0015075
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	PIEZO1 TRPC4 TRPC5 RYR3 KCNMB1 KCNN1 CACNA1F PKD2L1 ABCC9 PKD1L3 GRM7 CACNA2D4 PKD2L2 SLC15A1 ATP1A4 SLC12A7	1.28e-03	664	203	16	GO:0008324
GeneOntologyMolecularFunction	small GTPase binding	KNTC1 RIN2 HACE1 RAB29 DOCK2 IPO7 STRIP1 EXOC8 EXOC5 PKN2	1.71e-03	321	203	10	GO:0031267
GeneOntologyMolecularFunction	G protein-coupled receptor activity	SSTR4 CHRM1 CHRM5 OR1L1 TAAR6 GPR149 CCR1 ADGRF5 TAS2R46 OR5P2 OR2B3 GRM3 ACKR4 GRM4 GRM5 GRM7 OR8B8 LHCGR ADGRG2	1.75e-03	884	203	19	GO:0004930
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	TRPC4 TRPC5 RYR3 KCNMB1 KCNN1 CACNA1F PKD2L1 ABCC9 PKD1L3 GRM7 CACNA2D4 PKD2L2 SLC15A1 ATP1A4 SLC12A7	1.94e-03	627	203	15	GO:0022890
GeneOntologyMolecularFunction	G protein-coupled acetylcholine receptor activity	CHRM1 CHRM5	2.09e-03	7	203	2	GO:0016907
GeneOntologyMolecularFunction	phosphatidylinositol phospholipase C activity	CHRM1 CHRM5 CCR1	2.27e-03	26	203	3	GO:0004435
GeneOntologyMolecularFunction	calcium-activated cation channel activity	KCNMB1 KCNN1 PKD2L1	2.53e-03	27	203	3	GO:0005227
GeneOntologyMolecularFunction	adenosine receptor binding	ADA2 GRM5	2.77e-03	8	203	2	GO:0031685
GeneOntologyMolecularFunction	bubble DNA binding	ABL1 WRN	2.77e-03	8	203	2	GO:0000405
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway	GRM3 GRM4 GRM5 GRM7	1.13e-06	9	204	4	GO:0007196
GeneOntologyBiologicalProcess	icosanoid transport	SLCO2B1 SSTR4 ACE ABCC2 LEP LHCGR SLCO2A1	7.83e-06	73	204	7	GO:0071715
GeneOntologyBiologicalProcess	G protein-coupled glutamate receptor signaling pathway	GRM3 GRM4 GRM5 GRM7	1.54e-05	16	204	4	GO:0007216
GeneOntologyBiologicalProcess	actin filament-based movement	ADCY10 MYH6 MYO1A MYO7B MYO5C SYNE2 ABCC9 MYO1B CTNNA3	2.22e-05	153	204	9	GO:0030048
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	CHRM1 CHRM5 GRM3 GRM4 GRM5 GRM7 RGS2	2.32e-05	86	204	7	GO:0007193
GeneOntologyBiologicalProcess	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	ADCY10 SSTR4 CHRM1 CHRM5 ADGRF5 GRM3 GRM4 GRM5 GRM7 RGS2 LHCGR ADGRG2	2.95e-05	286	204	12	GO:0007188
GeneOntologyBiologicalProcess	negative regulation of amino acid transport	GRM7 RGS2 LEP SLC15A1	4.87e-05	21	204	4	GO:0051956
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of sour taste	PKD2L1 PKD1L3	9.73e-05	2	204	2	GO:0001581
GeneOntologyCellularComponent	cation channel complex	TRPC4 TRPC5 RYR3 KCNMB1 KCNN1 CACNA1F PKD2L1 ABCC9 PKD1L3 CACNA2D4 CNTNAP2 CATSPERG	3.59e-06	235	204	12	GO:0034703
GeneOntologyCellularComponent	calcium channel complex	TRPC4 TRPC5 RYR3 CACNA1F PKD2L1 CACNA2D4 CATSPERG	7.18e-06	73	204	7	GO:0034704
GeneOntologyCellularComponent	myosin complex	MYH6 MYO1A MYO7B MYO9A MYO5C MYO1B	2.35e-05	59	204	6	GO:0016459
GeneOntologyCellularComponent	apical part of cell	ADCY10 RIPOR2 MYO1A MYO7B SLCO2B1 FAP GPSM2 ADGRF5 ABCC2 FAT4 DSG1 UPK1A DDR2 MYO1B SLC15A1 ADGRG2 CYP4F12	7.48e-05	592	204	17	GO:0045177
GeneOntologyCellularComponent	cluster of actin-based cell projections	RIPOR2 MYO1A MYO7B ACE ABCC2 FLII MYO1B PKHD1L1 SLC15A1	3.56e-04	223	204	9	GO:0098862
GeneOntologyCellularComponent	monoatomic ion channel complex	TRPC4 TRPC5 RYR3 KCNMB1 KCNN1 CACNA1F PKD2L1 ABCC9 PKD1L3 CACNA2D4 CNTNAP2 CATSPERG	3.58e-04	378	204	12	GO:0034702
GeneOntologyCellularComponent	brush border	MYO1A MYO7B ACE ABCC2 FLII MYO1B SLC15A1	7.46e-04	152	204	7	GO:0005903
Domain	GPCR_3_mtglu_rcpt	GRM3 GRM4 GRM5 GRM7	8.47e-07	8	199	4	IPR000162
Domain	Myosin_head_motor_dom	MYH6 MYO1A MYO7B MYO9A MYO5C MYO1B	2.82e-06	38	199	6	IPR001609
Domain	MYOSIN_MOTOR	MYH6 MYO1A MYO7B MYO9A MYO5C MYO1B	2.82e-06	38	199	6	PS51456
Domain	Myosin_head	MYH6 MYO1A MYO7B MYO9A MYO5C MYO1B	2.82e-06	38	199	6	PF00063
Domain	MYSc	MYH6 MYO1A MYO7B MYO9A MYO5C MYO1B	2.82e-06	38	199	6	SM00242
Domain	PC1	PKD2L1 PKD1L3 PKD2L2	4.73e-06	4	199	3	IPR000434
Domain	NCD3G	GRM3 GRM4 GRM5 GRM7	8.29e-06	13	199	4	PF07562
Domain	GPCR_3_9-Cys_dom	GRM3 GRM4 GRM5 GRM7	8.29e-06	13	199	4	IPR011500
Domain	IQ	MYH6 MYO1A MYO7B MYO9A CAMTA2 MYO5C MYO1B	1.05e-05	71	199	7	PF00612
Domain	GPCR_3_CS	GRM3 GRM4 GRM5 GRM7	1.15e-05	14	199	4	IPR017979
Domain	IQ	MYH6 MYO1A MYO7B MYO9A CAMTA2 MYO5C MYO1B	2.50e-05	81	199	7	SM00015
Domain	Vinculin/catenin	TLN2 CTNNA3 CTNNA1	4.04e-05	7	199	3	IPR006077
Domain	IQ_motif_EF-hand-BS	MYH6 MYO1A MYO7B MYO9A CAMTA2 MYO5C MYO1B	4.97e-05	90	199	7	IPR000048
Domain	IQ	MYH6 MYO1A MYO7B MYO9A CAMTA2 MYO5C MYO1B	6.13e-05	93	199	7	PS50096
Domain	GPCR_3	GRM3 GRM4 GRM5 GRM7	6.49e-05	21	199	4	IPR000337
Domain	7tm_3	GRM3 GRM4 GRM5 GRM7	7.87e-05	22	199	4	PF00003
Domain	G_PROTEIN_RECEP_F3_2	GRM3 GRM4 GRM5 GRM7	7.87e-05	22	199	4	PS00980
Domain	G_PROTEIN_RECEP_F3_3	GRM3 GRM4 GRM5 GRM7	7.87e-05	22	199	4	PS00981
Domain	G_PROTEIN_RECEP_F3_1	GRM3 GRM4 GRM5 GRM7	7.87e-05	22	199	4	PS00979
Domain	G_PROTEIN_RECEP_F3_4	GRM3 GRM4 GRM5 GRM7	7.87e-05	22	199	4	PS50259
Domain	GPCR_3_C	GRM3 GRM4 GRM5 GRM7	7.87e-05	22	199	4	IPR017978
Domain	CXCXC_repeat	VEGFD VEGFC	1.13e-04	2	199	2	IPR004153
Domain	CXCXC	VEGFD VEGFC	1.13e-04	2	199	2	PF03128
Domain	PKD_channel	PKD2L1 PKD1L3 PKD2L2	1.85e-04	11	199	3	PF08016
Domain	PKD1_2_channel	PKD2L1 PKD1L3 PKD2L2	1.85e-04	11	199	3	IPR013122
Domain	RA	MYO9A RIN2 RASSF3 RADIL	3.14e-04	31	199	4	SM00314
Domain	Vitellinogen_superhlx	CAND1 APOB	3.36e-04	3	199	2	IPR011030
Domain	Laminin_G	COL14A1 HSPG2 FAT4 SLIT1 CNTNAP2	3.78e-04	58	199	5	IPR001791
Domain	RA	MYO9A RIN2 RASSF3 RADIL	5.64e-04	36	199	4	PF00788
Domain	ANF_lig-bd_rcpt	GRM3 GRM4 GRM5 GRM7	6.27e-04	37	199	4	IPR001828
Domain	ANF_receptor	GRM3 GRM4 GRM5 GRM7	6.27e-04	37	199	4	PF01094
Domain	RA	MYO9A RIN2 RASSF3 RADIL	6.27e-04	37	199	4	PS50200
Domain	Alpha_catenin	CTNNA3 CTNNA1	6.68e-04	4	199	2	IPR001033
Domain	VINCULIN_1	CTNNA3 CTNNA1	6.68e-04	4	199	2	PS00663
Domain	Vinculin_CS	CTNNA3 CTNNA1	6.68e-04	4	199	2	IPR000633
Domain	LAM_G_DOMAIN	HSPG2 FAT4 SLIT1 CNTNAP2	6.95e-04	38	199	4	PS50025
Domain	P-loop_NTPase	ADCY10 MYH6 MYO1A MYO7B MYO9A GBP3 NLRC4 MYO5C STARD9 SHPRH ABCC2 RAB29 DNAH3 WRN ABCC9 MYO1B HELQ ATL1 CHTF18 SNRNP200	7.53e-04	848	199	20	IPR027417
Domain	Peripla_BP_I	GRM3 GRM4 GRM5 GRM7	7.68e-04	39	199	4	IPR028082
Domain	Ubiquitin-rel_dom	MYO7B MYO9A RIN2 TLN2 RASSF3 VCPIP1 RADIL MAP1LC3C	8.16e-04	184	199	8	IPR029071
Domain	RA_dom	MYO9A RIN2 RASSF3 RADIL	8.46e-04	40	199	4	IPR000159
Domain	Laminin_G_2	HSPG2 FAT4 SLIT1 CNTNAP2	8.46e-04	40	199	4	PF02210
Domain	Musac_Ach_rcpt	CHRM1 CHRM5	1.11e-03	5	199	2	IPR000995
Domain	Vinculin	CTNNA3 CTNNA1	1.11e-03	5	199	2	PF01044
Domain	PKD_2	PKD2L1 PKD2L2	1.11e-03	5	199	2	IPR003915
Domain	WHTH_DNA-bd_dom	UBR1 COPS2 ANAPC2 SHPRH CUL1 WRN HELQ RFX4 SNRNP200	1.18e-03	242	199	9	IPR011991
Domain	LamG	HSPG2 FAT4 SLIT1 CNTNAP2	1.22e-03	44	199	4	SM00282
Domain	FA58C	F8 DDR2 CNTNAP2	1.38e-03	21	199	3	SM00231
Domain	FA58C_3	F8 DDR2 CNTNAP2	1.38e-03	21	199	3	PS50022
Domain	FA58C_1	F8 DDR2 CNTNAP2	1.38e-03	21	199	3	PS01285
Domain	FA58C_2	F8 DDR2 CNTNAP2	1.38e-03	21	199	3	PS01286
Domain	TRP_2	TRPC4 TRPC5	1.65e-03	6	199	2	PF08344
Domain	Dilute_dom	MYO5C RADIL	1.65e-03	6	199	2	IPR002710
Domain	TRP_dom	TRPC4 TRPC5	1.65e-03	6	199	2	IPR013555
Domain	DIL	MYO5C RADIL	1.65e-03	6	199	2	PF01843
Domain	DILUTE	MYO5C RADIL	1.65e-03	6	199	2	PS51126
Domain	DIL	MYO5C RADIL	1.65e-03	6	199	2	SM01132
Domain	F5_F8_type_C	F8 DDR2 CNTNAP2	2.04e-03	24	199	3	PF00754
Domain	FA58C	F8 DDR2 CNTNAP2	2.04e-03	24	199	3	IPR000421
Domain	CULLIN	ANAPC2 CUL1	2.29e-03	7	199	2	SM00182
Domain	TRPC_channel	TRPC4 TRPC5	2.29e-03	7	199	2	IPR002153
Domain	PD_growth_factor_CS	VEGFD VEGFC	2.29e-03	7	199	2	IPR023581
Domain	Myosin_TH1	MYO1A MYO1B	2.29e-03	7	199	2	PF06017
Domain	Myosin_TH1	MYO1A MYO1B	2.29e-03	7	199	2	IPR010926
Domain	TH1	MYO1A MYO1B	2.29e-03	7	199	2	PS51757
Pathway	WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE	GRM3 GRM4 GRM5 GRM7	1.49e-05	15	149	4	M39442
Pathway	WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE	GRM3 GRM4 GRM5 GRM7	1.49e-05	15	149	4	MM15845
Pathway	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	TAS2R46 GRM3 GRM4 GRM5 GRM7	4.09e-05	37	149	5	MM15067
Pathway	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	TAS2R46 GRM3 GRM4 GRM5 GRM7	5.32e-05	39	149	5	M793
Pubmed	A biological consequence of variation in the site of D-JH gene rearrangement.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	6434992
Pubmed	An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	6769593
Pubmed	Crossreactive B cells are present during a primary but not secondary response in BALB/c mice expressing a bcl-2 transgene.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	10449099
Pubmed	Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	3135325
Pubmed	Structure of the T15 VH gene subfamily: identification of immunoglobulin gene promotor homologies.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	3108392
Pubmed	The D segment defines the T15 idiotype: the immunoresponse of A/J mice to Pneumococcus pneumoniae.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	6499907
Pubmed	Antibody diversity: somatic hypermutation of rearranged VH genes.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	6101208
Pubmed	Developmentally controlled expression of immunoglobulin VH genes.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	3975629
Pubmed	Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic clone containing variable and alpha constant regions.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	106394
Pubmed	Idiotype-specific Th cells support oligoclonal expansion of anti-dsDNA B cells in mice with lupus.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	25127856
Pubmed	Defective secretion of an immunoglobulin caused by mutations in the heavy chain complementarity determining region 2.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	8046334
Pubmed	Repertoire shift in the humoral response to phosphocholine-keyhole limpet hemocyanin: VH somatic mutation in germinal center B cells impairs T15 Ig function.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	12734355
Pubmed	Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	21068211
Pubmed	Mouse monoclonal antibodies to pneumococcal C-polysaccharide backbone show restricted usage of VH-DH-JH gene segments and share the same kappa chain.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	19428559
Pubmed	Clonal Progression during the T Cell-Dependent B Cell Antibody Response Depends on the Immunoglobulin DH Gene Segment Repertoire.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	25157256
Pubmed	Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	2748602
Pubmed	An immunoglobulin promoter region is unaltered by DNA rearrangement and somatic mutation during B-cell development.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	6296789
Pubmed	Somatic evolution of diversity among anti-phosphocholine antibodies induced with Proteus morganii.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	3106498
Pubmed	Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	8750831
Pubmed	Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	819932
Pubmed	Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	3104790
Pubmed	A V region mutation in a phosphocholine-binding monoclonal antibody results in loss of antigen binding.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	2005389
Pubmed	Sequence and fine specificity analysis of primary 511 anti-phosphorylcholine antibodies.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.22e-09	4	207	4	2512348
Pubmed	IgD+IgM- B cells mount immune responses that exhibit altered antibody repertoire.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	6.07e-09	5	207	4	14991595
Pubmed	An intrinsic propensity of murine peritoneal B1b cells to switch to IgA in presence of TGF-β and retinoic acid.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	6.07e-09	5	207	4	24324757
Pubmed	Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	6.07e-09	5	207	4	10367906
Pubmed	Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	CAND1 SLCO2B1 MCF2L2 CAMTA2 TBC1D9 ADGRF5 EHBP1 ZHX2 CNTNAP2	9.38e-09	100	207	9	10048485
Pubmed	Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.	MYO1A MYO7B MYO9A MYO5C MYO1B	1.36e-08	14	207	5	8022818
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	KNTC1 MYO5C FLII IPO7 SMCHD1 WRN MYO1B PARP14 CNTNAP2 CNOT1 SNRNP200	4.10e-08	202	207	11	33005030
Pubmed	Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion.	GRM3 GRM4 GRM5 GRM7	4.21e-08	7	207	4	9920659
Pubmed	Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival.	GRM3 GRM4 GRM5	2.08e-07	3	207	3	30488581
Pubmed	Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors.	GRM3 GRM4 GRM5 GRM7	2.49e-07	10	207	4	9069281
Pubmed	Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.	BCHE ACE CHRM1 CHRM5 GRM3 GRM4 GRM5 GRM7	5.74e-07	118	207	8	19156168
Pubmed	Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population.	PER3 DUSP6 GRM3 GRM4 GRM7 RFX4	6.70e-07	52	207	6	19328558
Pubmed	A quantitative analysis of the spatiotemporal pattern of transient receptor potential gene expression in the developing mouse cochlea.	TRPC4 TRPC5 PKD2L1 PKD1L3 PKD2L2	1.47e-06	33	207	5	19834762
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	RNF130 CAND1 ORC6 ANAPC2 TLN2 DOCK2 CUL1 IPO7 SMCHD1 EXOC5 PKN2 CTNNA1 CNOT1 SNRNP200 CPSF3	2.48e-06	582	207	15	20467437
Pubmed	HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders.	GRM3 GRM4 GRM5 GRM7 RGS2	3.04e-06	38	207	5	25613138
Pubmed	Transient receptor potential channels and their role in modulating radial glial-neuronal interaction: a signaling pathway involving mGluR5.	TRPC4 TRPC5 GRM5	4.10e-06	6	207	3	25347706
Pubmed	Developmental waves of mechanosensitivity acquisition in sensory neuron subtypes during embryonic development.	TRPC4 TRPC5 PKD2L1 PKD1L3 PKD2L2	6.40e-06	44	207	5	19322198
Pubmed	A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.	MYO1A MYO7B FLII MYO1B SLC15A1	7.16e-06	45	207	5	22114352
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	CAND1 MYO1A COPS2 OTUD7B EIF3L SHPRH VCPIP1 CUL1 IPO7 DSG1 WRN UBA3 STRIP1 EXOC8 PKN2 EIF3F PAN3 CNOT1 SNRNP200	1.03e-05	1005	207	19	19615732
Pubmed	Mapping genetic modulators of amyloid plaque deposition in TgCRND8 transgenic mice.	RNF130 HSPG2 WRN	1.14e-05	8	207	3	16785251
Pubmed	Glutamate can act as a signaling molecule in mouse preimplantation embryos†.	GRM3 GRM4 GRM5 GRM7	1.18e-05	24	207	4	35746896
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	SSTR4 CHRM1 CHRM5 GRM3 GRM4 GRM5 GRM7 LEP LHCGR CNTNAP2	1.41e-05	300	207	10	19086053
Pubmed	A cascading activity-based probe sequentially targets E1-E2-E3 ubiquitin enzymes.	CAND1 OTUD7B SYNE2 HACE1 UGP2 UBA3	1.49e-05	88	207	6	27182664
Pubmed	Characterization of the role of COP9 signalosome in regulating cullin E3 ubiquitin ligase activity.	CAND1 COPS2 CUL1	1.70e-05	9	207	3	22013077
Pubmed	The repertoire of olfactory C family G protein-coupled receptors in zebrafish: candidate chemosensory receptors for amino acids.	GRM3 GRM4 GRM7	2.42e-05	10	207	3	17156446
Pubmed	Two members of the TRPP family of ion channels, Pkd1l3 and Pkd2l1, are co-expressed in a subset of taste receptor cells.	PKD2L1 PKD1L3 PKD2L2	2.42e-05	10	207	3	16805797
Pubmed	L-type voltage-dependent calcium channel alpha subunit 1C is a novel candidate gene associated with secondary hyperparathyroidism: an application of haplotype-based analysis for multiple linked single nucleotide polymorphisms.	RYR3 KCNMB1 SLC2A3 LHCGR SLC14A1 SLC15A1 SLCO2A1	2.52e-05	143	207	7	20424473
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	TRPC4 DPYSL5 SSTR4 OTUD7B RIN2 PKD2L1 ABCC9 MYO1B TPGS2 ACKR4 PKHD1L1 ARHGEF10L RADIL SLIT1 CTNNA3 CNTNAP2	3.32e-05	814	207	16	23251661
Pubmed	HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA.	FBXL5 EIF3L WRN EIF3F	3.38e-05	31	207	4	30279242
Pubmed	[Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].	VEGFD VEGFC	3.53e-05	2	207	2	17222375
Pubmed	Off-response property of an acid-activated cation channel complex PKD1L3-PKD2L1.	PKD2L1 PKD1L3	3.53e-05	2	207	2	18535624
Pubmed	Interaction between PKD1L3 and PKD2L1 through their transmembrane domains is required for localization of PKD2L1 at taste pores in taste cells of circumvallate and foliate papillae.	PKD2L1 PKD1L3	3.53e-05	2	207	2	20538909
Pubmed	Acetic acid activates PKD1L3-PKD2L1 channel--a candidate sour taste receptor.	PKD2L1 PKD1L3	3.53e-05	2	207	2	19464260
Pubmed	The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists.	CHRM1 CHRM5	3.53e-05	2	207	2	16877267
Pubmed	Risk of Developing Hepatocellular Carcinoma following Depressive Disorder Based on the Expression Level of Oatp2a1 and Oatp2b1.	SLCO2B1 SLCO2A1	3.53e-05	2	207	2	31467884
Pubmed	A novel PKD2L1 C-terminal domain critical for trimerization and channel function.	PKD2L1 PKD1L3	3.53e-05	2	207	2	25820328
Pubmed	Localisation of lymphatic vessels and vascular endothelial growth factors-C and -D in human and mouse skeletal muscle with immunohistochemistry.	VEGFD VEGFC	3.53e-05	2	207	2	16924525
Pubmed	The cell cycle of early mammalian embryos: lessons from genetic mouse models.	ANAPC2 UBA3	3.53e-05	2	207	2	16481745
Pubmed	Diminished antigen-specific IgG1 and interleukin-6 production and acetylcholinesterase expression in combined M1 and M5 muscarinic acetylcholine receptor knockout mice.	CHRM1 CHRM5	3.53e-05	2	207	2	17586055
Pubmed	VEGF-C and VEGF-D overexpression is more common in left-sided and well-differentiated colon adenocarcinoma.	VEGFD VEGFC	3.53e-05	2	207	2	24173916
Pubmed	Structure of the Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the assembly of the multisubunit cullin-dependent ubiquitin ligases.	CAND1 CUL1	3.53e-05	2	207	2	15537541
Pubmed	Apolipoprotein B and angiotensin-converting enzyme polymorphisms and aerobic interval training: randomized controlled trial in coronary artery disease patients.	ACE APOB	3.53e-05	2	207	2	29846435
Pubmed	Selective Gαi subunits as novel direct activators of transient receptor potential canonical (TRPC)4 and TRPC5 channels.	TRPC4 TRPC5	3.53e-05	2	207	2	22457348
Pubmed	Conserved gating elements in TRPC4 and TRPC5 channels.	TRPC4 TRPC5	3.53e-05	2	207	2	23677990
Pubmed	Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis.	VEGFD VEGFC	3.53e-05	2	207	2	15623620
Pubmed	The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma.	VEGFD VEGFC	3.53e-05	2	207	2	19589137
Pubmed	αE-catenin is an autoinhibited molecule that coactivates vinculin.	CTNNA3 CTNNA1	3.53e-05	2	207	2	22586082
Pubmed	Activating mGlu3 Metabotropic Glutamate Receptors Rescues Schizophrenia-like Cognitive Deficits Through Metaplastic Adaptations Within the Hippocampus.	GRM3 GRM5	3.53e-05	2	207	2	33965197
Pubmed	Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3.	SLCO2B1 SLCO2A1	3.53e-05	2	207	2	26692285
Pubmed	Acute Treatment with a Novel TRPC4/C5 Channel Inhibitor Produces Antidepressant and Anxiolytic-Like Effects in Mice.	TRPC4 TRPC5	3.53e-05	2	207	2	26317356
Pubmed	Non-dipping and arterial hypertension depend on clinical factors rather than on genetic variability of ACE and RGS2 genes in patients with type 1 diabetes.	ACE RGS2	3.53e-05	2	207	2	24562335
Pubmed	Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.	VEGFD VEGFC	3.53e-05	2	207	2	25911567
Pubmed	[Expression of VEGF-C and VEGF-D in gastric carcinoma and its relationship with lymph node metastases].	VEGFD VEGFC	3.53e-05	2	207	2	20448355
Pubmed	The single pore residue Asp523 in PKD2L1 determines Ca2+ permeation of the PKD1L3/PKD2L1 complex.	PKD2L1 PKD1L3	3.53e-05	2	207	2	21185261
Pubmed	Celastrol Targets Cullin-Associated and Neddylation-Dissociated 1 to Prevent Fibroblast-Myofibroblast Transformation against Pulmonary Fibrosis.	CAND1 CUL1	3.53e-05	2	207	2	36076154
Pubmed	Metabotropic glutamate receptors regulate differentiation of embryonic stem cells into GABAergic neurons.	GRM4 GRM5	3.53e-05	2	207	2	18174899
Pubmed	Serum vascular endothelial growth factors C and D as forecast tools for patients with gallbladder carcinoma.	VEGFD VEGFC	3.53e-05	2	207	2	25801241
Pubmed	Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.	VEGFD VEGFC	3.53e-05	2	207	2	23054001
Pubmed	Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.	VEGFD VEGFC	3.53e-05	2	207	2	22906075
Pubmed	Metabotropic glutamate receptors are expressed in adult human glial progenitor cells.	GRM3 GRM5	3.53e-05	2	207	2	15158450
Pubmed	Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.	VEGFD VEGFC	3.53e-05	2	207	2	27852824
Pubmed	[Relationship between clinicopathologic characteristics and expression of VEGF-C and VEGF-D in esophageal squamous cancer].	VEGFD VEGFC	3.53e-05	2	207	2	19462898
Pubmed	Roles of metabotropic glutamate receptors in glial function and glial-neuronal communication.	GRM3 GRM5	3.53e-05	2	207	2	8915890
Pubmed	TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A.	TRPC4 TRPC5	3.53e-05	2	207	2	30038709
Pubmed	VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis.	VEGFD VEGFC	3.53e-05	2	207	2	23695550
Pubmed	Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2.	VEGFD VEGFC	3.53e-05	2	207	2	11683876
Pubmed	Transient receptor potential family members PKD1L3 and PKD2L1 form a candidate sour taste receptor.	PKD2L1 PKD1L3	3.53e-05	2	207	2	16891422
Pubmed	Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium.	VEGFD VEGFC	3.53e-05	2	207	2	19717640
Pubmed	Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction.	VEGFD VEGFC	3.53e-05	2	207	2	22932121
Pubmed	Distinct Characteristics of VEGF-D and VEGF-C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease.	VEGFD VEGFC	3.53e-05	2	207	2	32319336
Pubmed	Changes in the expression of genes encoding for mGlu4 and mGlu5 receptors and other regulators of the indirect pathway in acute mouse models of drug-induced parkinsonism.	GRM4 GRM5	3.53e-05	2	207	2	25747602
Pubmed	Analysis of CD8+ T cell-mediated anti-viral responses in mice with targeted deletions of the M1 or M5 muscarinic cholinergic receptors.	CHRM1 CHRM5	3.53e-05	2	207	2	17286988
Pubmed	Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases.	VEGFD VEGFC	3.53e-05	2	207	2	18512120
Pubmed	Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer.	VEGFD VEGFC	3.53e-05	2	207	2	20672317
Pubmed	[Expression and significance of VEGF-C and VEGF-D in differentiated thyroid carcinoma].	VEGFD VEGFC	3.53e-05	2	207	2	19771906
Pubmed	VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue.	VEGFD VEGFC	3.53e-05	2	207	2	25640364
Pubmed	Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita.	COPS2 NR0B1	3.53e-05	2	207	2	10713076
Pubmed	Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer.	VEGFD VEGFC	3.53e-05	2	207	2	19117016
Interaction	LRRC31 interactions	KNTC1 MYO5C FLII IPO7 SMCHD1 WRN MYO1B PARP14 CNTNAP2 CNOT1 SNRNP200	6.70e-06	205	200	11	int:LRRC31
GeneFamily	Glutamate metabotropic receptors\|Protein phosphatase 1 regulatory subunits	GRM3 GRM4 GRM5 GRM7	2.86e-07	8	147	4	281
GeneFamily	Transient receptor potential cation channels	TRPC4 TRPC5 PKD2L1 PKD2L2	7.38e-05	28	147	4	249
GeneFamily	Cholinergic receptors muscarinic	CHRM1 CHRM5	6.46e-04	5	147	2	180
GeneFamily	VEGF family	VEGFD VEGFC	6.46e-04	5	147	2	1267
GeneFamily	Myosins, class I	MYO1A MYO1B	1.78e-03	8	147	2	1097
GeneFamily	Exocyst complex	EXOC8 EXOC5	2.28e-03	9	147	2	1055
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	RIPOR2 INPP4A PGM2L1 UBN2 CSMD3 CHRM5 TBC1D9 ERAP2 TLN2 DOP1B PDZRN4 COL6A6 KIAA1549 GRM3 GRM4 GRM5 GRM7 ATL1 STRIP1 FRY CNTNAP2 TENM1 CATSPERG	2.19e-05	1106	206	23	M39071
Coexpression	GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN	TRPC5 HACE1 CCR1 ABCC2 VEGFC DSG1 GRM3 RFX4 ATL1	2.86e-05	198	206	9	M9396
Coexpression	GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN	RNF130 TBC1D9 MYO5C GPR149 HSD17B3 DUSP6 ABCC9 GRM4 DTWD2	2.98e-05	199	206	9	M8086
Coexpression	GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN	RNF130 RIN2 KCNMB1 CCR1 DUSP6 UBA3 CTSA ARHGEF10L CTNNA1	3.10e-05	200	206	9	M4506
Coexpression	GSE10325_BCELL_VS_MYELOID_DN	RNF130 ADA2 RIN2 KCNMB1 CCR1 DUSP6 CTSA RGS2 TBC1D8	3.10e-05	200	206	9	M3082
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B CSMD3 CHRM1 RYR3 FREM2 DISP3 TLN2 CACNA1F FAT4 APOB PKHD1L1 TENM1 ATP1A4	4.10e-12	184	207	13	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B CSMD3 CHRM1 RYR3 FREM2 DISP3 TLN2 CACNA1F FAT4 APOB PKHD1L1 TENM1 ATP1A4	4.10e-12	184	207	13	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B CSMD3 CHRM1 RYR3 FREM2 DISP3 TLN2 CACNA1F FAT4 APOB PKHD1L1 TENM1 ATP1A4	4.10e-12	184	207	13	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	NUP210L CSMD3 TTC6 PDZRN4 DNAH3 GRM5 GRM7 CTNNA3 CNTNAP2	6.08e-08	159	207	9	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	ileum\|World / shred on tissue and cell subclass	MYO1A MYO7B ACE ERAP2 ABCC2 TMIGD1 APOB SLC15A1 CYP4F12	1.08e-07	170	207	9	9f1211bd4287620e19a59f21e6ecdca3e42e0260
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DPYSL5 KCNMB1 PDZRN4 UPK1A APOB TEX14 RGS2 ADGRG2 ACOT11	1.32e-07	174	207	9	c529f3674b784f872f4387ffdeb46aecb619976b
ToppCell	Control-Classical_Monocyte-cMono_2\|Control / Disease condition and Cell class	RIPOR2 ADA2 FBXL5 CCR1 SMCHD1 DUSP6 CTSA RGS2 SLC2A3	3.46e-07	195	207	9	0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE8A ACE FNDC1 CPQ UGP2 COL14A1 DDR2 ACKR4 ADGRG2	3.61e-07	196	207	9	ed6047b48b6a96baa6a90c7af784e7c34b32824d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PDE8A TRPC4 FAP STARD9 FAT4 ABCC9 MYO1B SLC2A3 SLC12A7	3.77e-07	197	207	9	2872a78b1be61aa1d50bc9a49294a21e922dc033
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_2\|COVID-19_Convalescent / Disease condition and Cell class	RNF130 RIPOR2 ADA2 FBXL5 VMP1 SMCHD1 DUSP6 RGS2 SLC2A3	3.93e-07	198	207	9	f65fd9b773aeafa55e38309479954a8e41371f52
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 STARD9 COL14A1 PRRX2 PDZRN4 FAT4 DDR2 ABCC9 TENM1	4.28e-07	200	207	9	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	C_02\|World / shred on cell type and cluster	MYO1A ACE ABCC2 DNASE1 TMIGD1 APOB SLC15A1 CYP4F12	1.08e-06	165	207	8	a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 ACKR4 GRM5 GRM7 SLIT1 DNAI4 CFAP57 CFAP46	1.30e-06	169	207	8	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	368C-Myeloid-Monocyte-CD16+_Monocyte\|Monocyte / Donor, Lineage, Cell class and subclass (all cells)	MYO1A INPP4A MYO5C TMEM106C SHPRH KCNN1 ADGRF5 RNASEH1	1.36e-06	170	207	8	4a19c7e3bb0f9c2601a10debe7000066789b4150
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRPC4 TRPC5 FAP RASSF3 PDZRN4 SLCO2A1 SLIT1 CTNNA3	1.62e-06	174	207	8	0df738309b7b6e77675ea74e7a87e66601b0073d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRPC4 TRPC5 FAP PDZRN4 VEGFC SLCO2A1 SLIT1 CTNNA3	1.84e-06	177	207	8	64fbf799e7b0c4003b2f486cc41b0f7e7c11ea0c
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRPC4 TRPC5 FREM2 FAP VEGFC SLCO2A1 SLIT1 CTNNA3	2.17e-06	181	207	8	13270b6ba6a9c8e5681c6f40000c643ce1d9344a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRPC4 TRPC5 FREM2 FAP VEGFC SLCO2A1 SLIT1 CTNNA3	2.17e-06	181	207	8	3e3c903b522dced6bec5dc447cc3f8bf9a9749e3
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Nefl_(Neurofilament_state)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ADCY10 MGAT4D CCDC168 ACOT4 DNASE1	2.31e-06	46	207	5	37ea73d291e35b6865bd3ea4857275a6e5b299d1
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Nefl_(Neurofilament_state)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ADCY10 MGAT4D CCDC168 ACOT4 DNASE1	2.31e-06	46	207	5	69e9c8cbae3d15bd0823b8c6e48a9d2b9815296b
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Lypd1_(CA1_Principal_cells_(Anterior))\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH6 SSTR4 CHRM5 VEGFD CACNA1F ATP1A4	2.66e-06	84	207	6	52d167614afa9b056f2934142d3250fe5e70e806
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ACE FNDC1 UGP2 COL14A1 DDR2 ACKR4 RADIL ADGRG2	2.76e-06	187	207	8	0d4b7da81036c2aa678654b9fe49c939d08fcd9b
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPYSL5 CHRM1 FNDC1 TLN2 KIAA1549 ACKR4 FRY SLCO2A1	2.99e-06	189	207	8	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO2B1 FNDC1 CPQ COL14A1 PRRX2 HSPG2 DDR2 ABCC9	3.23e-06	191	207	8	2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	FAP FNDC1 COL14A1 VEGFD COL6A6 DDR2 ACKR4 TENM1	3.23e-06	191	207	8	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	FAP FNDC1 COL14A1 VEGFD COL6A6 DDR2 ACKR4 TENM1	3.23e-06	191	207	8	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	F8 RIN2 SYNE2 ADGRF5 VEGFC HSPG2 PKHD1L1 SLCO2A1	3.23e-06	191	207	8	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO2B1 FNDC1 CPQ COL14A1 PRRX2 HSPG2 DDR2 ABCC9	3.36e-06	192	207	8	a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO2B1 FNDC1 CPQ COL14A1 PRRX2 HSPG2 DDR2 ABCC9	3.36e-06	192	207	8	7b48df661f61ce494bf6f0b9a74b0422e29c24bf
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	F8 RIN2 SYNE2 ADGRF5 VEGFC HSPG2 PKHD1L1 SLCO2A1	3.36e-06	192	207	8	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	F8 SYNE2 ADGRF5 VEGFC HSPG2 SLC2A3 TBC1D8 SLCO2A1	3.36e-06	192	207	8	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	facs-Lung-nan-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO2B1 FNDC1 CPQ COL14A1 PRRX2 HSPG2 DDR2 ABCC9	3.36e-06	192	207	8	eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO2B1 FNDC1 CPQ COL14A1 PRRX2 HSPG2 DDR2 ABCC9	3.36e-06	192	207	8	32acd89617934016cd135d2cc797e8e79ae1b37f
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO2B1 FNDC1 CPQ COL14A1 PRRX2 HSPG2 DDR2 ABCC9	3.36e-06	192	207	8	011634a24b0c61d9b463fe755502edbc5cd70b7a
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	F8 RIN2 SYNE2 ADGRF5 HSPG2 PARP14 PKHD1L1 SLCO2A1	3.49e-06	193	207	8	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO2B1 FNDC1 COL14A1 VEGFD PRRX2 HSPG2 DDR2 ABCC9	3.49e-06	193	207	8	858a186804b36d45957238d3d3eed2768b961641
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO2B1 FNDC1 COL14A1 VEGFD PRRX2 HSPG2 DDR2 ABCC9	3.49e-06	193	207	8	7865e7ec0a288249540d4cba94ae01c93e1b617c
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO2B1 FNDC1 CPQ COL14A1 PRRX2 HSPG2 DDR2 ABCC9	3.49e-06	193	207	8	fe9720185929ef849edd1b8eb4854306b392e5a2
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO2B1 FNDC1 CPQ COL14A1 PRRX2 HSPG2 DDR2 ABCC9	3.49e-06	193	207	8	e27885a9e1a2a3e165c5366d4cfcda05c5454483
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO2B1 FNDC1 CPQ COL14A1 VEGFD PRRX2 DDR2 ABCC9	3.63e-06	194	207	8	c9e589fe7df6a9b377654581a2aebb607cbb03b9
ToppCell	facs-Marrow-B-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B DISP3 PDZRN4 TMIGD1 GRM7 CLCA2 CATSPERG	3.66e-06	137	207	7	4dcb15de821439011df1bb0bbd7682d674bd725d
ToppCell	facs-Marrow-B-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B DISP3 PDZRN4 TMIGD1 GRM7 CLCA2 CATSPERG	3.66e-06	137	207	7	c05ceeb7b483324604cb3f647d2da2b3786071b1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACE ADGRF5 VEGFD VEGFC HSPG2 MYO1B FRY SLCO2A1	3.77e-06	195	207	8	4658fb197657d7692ee344ae76b11b0210c418ba
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RYR3 STARD9 ADGRF5 RASSF3 VEGFC HSPG2 SLC14A1 SLCO2A1	3.91e-06	196	207	8	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	15-Trachea-Mesenchymal\|Trachea / Age, Tissue, Lineage and Cell class	BCHE FAP FNDC1 COL14A1 PRRX2 FAT4 COL6A6 DDR2	3.91e-06	196	207	8	7e178c76285e61c721c38d7a995ebf89dc428f9f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RYR3 STARD9 ADGRF5 RASSF3 VEGFC HSPG2 SLC14A1 SLCO2A1	3.91e-06	196	207	8	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high\|Trachea / Age, Tissue, Lineage and Cell class	BCHE FAP FNDC1 COL14A1 PRRX2 FAT4 COL6A6 DDR2	3.91e-06	196	207	8	54aefcebf13704f51de84379e2e22ec0734b9461
ToppCell	COVID-19_Moderate-Classical_Monocyte\|World / disease group, cell group and cell class	RNF130 ADA2 CCR1 VMP1 DUSP6 PARP14 RGS2 AP5B1	4.06e-06	197	207	8	16cf3939e700aef1e16159f0652ba2dfad287e7a
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	F8 RIN2 SYNE2 ADGRF5 HSPG2 KIAA1549 SLC14A1 SLCO2A1	4.06e-06	197	207	8	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GBP3 ACE SYNE2 ADGRF5 SMCHD1 PARP14 FRY CTNNA1	4.54e-06	200	207	8	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPC4 BCHE FNDC1 COL14A1 PRRX2 PDZRN4 FRY CTNNA3	4.54e-06	200	207	8	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ACE F8 ADGRF5 DUSP6 SLC2A3 FRY SLC14A1 SLCO2A1	4.54e-06	200	207	8	30dc7ffef2052ee8610cdca952ca12f240bcec50
ToppCell	COVID-19-kidney-Technical/muscle\|kidney / Disease (COVID-19 only), tissue and cell type	MGAT4D CSMD3 DNAH3 DSG1 GRM7 CTNNA3 CNTNAP2	6.09e-06	148	207	7	0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e
ToppCell	Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NUP210L TNFSF4 FAP COL14A1 TEX14 CATSPERG	6.92e-06	99	207	6	98c40a27432929434879c9e7283a14102f405f39
ToppCell	Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NUP210L TNFSF4 FAP COL14A1 TEX14 CATSPERG	6.92e-06	99	207	6	d6bd8075dc7aba2034ea78b1389868282bc80a2d
ToppCell	COVID-19-kidney-Epithelial_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	F8 ADGRF5 HSPG2 UPK1A SLCO2A1 CTNNA3 CNTNAP2	1.01e-05	160	207	7	0d4880f85565d8c540c94a8f8109147b3029279a
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CHRM5 FNDC1 COL6A6 TEX14 PKD1L3	1.03e-05	62	207	5	9db88da996b9977f5a89afe505cd55e7b5324bc9
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CHRM5 FNDC1 COL6A6 TEX14 PKD1L3	1.03e-05	62	207	5	461d280a1b955033186cfc326f9ace85b4a53c54
ToppCell	Influenza_Severe-Neutrophil\|Influenza_Severe / Disease group and Cell class	RIPOR2 MYO7B MYO5C VMP1 RGS2 SLC2A3 KRT23	1.06e-05	161	207	7	98c95b1b85d5427415af2ca8fb14849e97f6e8b5
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADCY10 CSMD3 FREM2 ABCC2 PKD2L1 PKHD1L1 TENM1	1.10e-05	162	207	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	NUP210L CSMD3 DOCK2 DNAH3 GRM7 CTNNA3 CNTNAP2	1.14e-05	163	207	7	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NUP210L CSMD3 TTC6 KCNN1 DNAH3 CTNNA3 CNTNAP2	1.34e-05	167	207	7	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	368C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MYO1A INPP4A MYO5C TMEM106C KCNN1 ADGRF5 RNASEH1	1.34e-05	167	207	7	dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7\|TCGA-Endometrium / Sample_Type by Project: Shred V9	BCHE RYR3 STARD9 KCNMB1 PDZRN4 ABCC9 CTNNA3	1.39e-05	168	207	7	a97e8e07ba949b30805aeed5f60fa5e092b9d3d4
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue\|TCGA-Endometrium / Sample_Type by Project: Shred V9	BCHE RYR3 STARD9 KCNMB1 PDZRN4 ABCC9 CTNNA3	1.50e-05	170	207	7	516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium\|TCGA-Endometrium / Sample_Type by Project: Shred V9	BCHE RYR3 STARD9 KCNMB1 PDZRN4 ABCC9 CTNNA3	1.50e-05	170	207	7	cdc19013da7c41d1ed8400a6a643e4c684ff9912
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal\|TCGA-Endometrium / Sample_Type by Project: Shred V9	BCHE RYR3 STARD9 KCNMB1 PDZRN4 ABCC9 CTNNA3	1.50e-05	170	207	7	0bde0a40440c7fdf7ba89cac8831d4014e7a4807
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BCHE RYR3 FNDC1 GPR149 RIN2 FAT4 RGS2	1.50e-05	170	207	7	36dbbdb13f69307afd2122ff051b2980850c1f00
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC4 PDZRN4 ABCC9 MYO1B FRY SLC14A1 CTNNA3	1.95e-05	177	207	7	4943d040eee0f9dceaddc7498171281d170e271f
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	BCHE FAP COL14A1 PRRX2 HSPG2 FAT4 DDR2	1.95e-05	177	207	7	3d955ea938a1d2fb1b6d68d4997fd454bd632dfc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC4 PDZRN4 ABCC9 MYO1B FRY SLC14A1 CTNNA3	1.95e-05	177	207	7	3f2272b577c862dba8ccfb41184054bbd0ace6f5
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STARD9 ADGRF5 HSPG2 PARP14 SLC2A3 RADIL SLCO2A1	2.02e-05	178	207	7	375156ba1c7b8592bf733c75f24968161f7cfa09
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NOL10 UGP2 GPSM2 CCR1 PRRX2 KNSTRN ARHGEF10L	2.10e-05	179	207	7	af03705a783e77f75c44fdfa793cfdccbf9dd91c
ToppCell	droplet-Lung-nan-21m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 RYR3 GPR149 TBC1D8 SLC14A1 ACOT11 CATSPERG	2.10e-05	179	207	7	d78eacf47847a50888dd16c35bed9b7afc80010f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RYR3 PDZRN4 DDR2 ABCC9 GRM4 SLIT1 TENM1	2.25e-05	181	207	7	08f44323bf71b6004a921bbc969c954c75feeb66
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE8A ACE FAP FNDC1 PRRX2 DDR2 ABCC9	2.42e-05	183	207	7	5cfcd589a480e67654d3d94e71916f122150db10
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE8A ACE FAP FNDC1 PRRX2 DDR2 ABCC9	2.42e-05	183	207	7	c3ea8d3b916ffcaca3156e0d77a952724554c4ab
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE8A ACE FAP FNDC1 PRRX2 DDR2 ABCC9	2.42e-05	183	207	7	81003ddc24164959dd41bb12fcac72638789b8f2
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TTC6 MYO5C FREM2 FRY PLPP2 SLC15A1 CTNNA3	2.42e-05	183	207	7	c5b10571599dc26476170b54b53f09c23e6b3117
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F8 RYR3 LRRC18 ACKR4 PKHD1L1 EPG5 CLCA2	2.42e-05	183	207	7	919c9861073d12fd12aecd7469b1478b13838c43
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE8A ACE FAP FNDC1 VEGFD PRRX2 DDR2	2.59e-05	185	207	7	00258f458cbf6d36449db95528a6b5038d731d2d
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE8A ACE FAP FNDC1 VEGFD PRRX2 DDR2	2.59e-05	185	207	7	3cd0686a14e734a0f243070ab939adcb4c454478
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE8A ACE FAP FNDC1 VEGFD PRRX2 DDR2	2.59e-05	185	207	7	a94694e226856bc5b168464f52d76004145717a5
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAP FNDC1 COL14A1 PRRX2 DDR2 GRM3 GRM7	2.68e-05	186	207	7	94d577dbb6bfacf50632e1fe8af041b35a1e6b23
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO2B1 FNDC1 COL14A1 PRRX2 HSPG2 DDR2 ABCC9	2.68e-05	186	207	7	7c1807fca590cdccf7f5734460bac228d33964ca
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GBP3 ACE DOP1B FLII FRY SLC12A7 CCDC180	2.77e-05	187	207	7	3699d5e71d779da922920aa3160895db187bf81b
ToppCell	5'-Adult-LymphNode-Hematopoietic-Myeloid-Macrophages\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNF130 SLCO2B1 ADA2 NLRC4 CCR1 TEX14 RGS2	2.77e-05	187	207	7	00930e407beaa337f72533a69f32d150faad8b9a
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GBP3 ACE DOP1B FLII FRY SLC12A7 CCDC180	2.77e-05	187	207	7	033ba52c0c2f9978784947098fa697368ae44834
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FNDC1 GPSM2 COL14A1 PRRX2 HSPG2 DDR2 ABCC9	2.77e-05	187	207	7	ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RYR3 FREM2 KCNMB1 RASSF3 PDZRN4 ABCC9 CTNNA3	2.77e-05	187	207	7	3912bbb610a4a84791e9bda92a2d57a52c31d29e
ToppCell	droplet-Liver-nan-3m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUL1 RFX4 RGS2 FRY SLIT1 CCDC180	2.87e-05	127	207	6	39fa20a55de3af1a62ab5dfa4877879db3935ac2
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH6 ACE FNDC1 COL14A1 PRRX2 HSPG2 ABCC9	2.87e-05	188	207	7	6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FAP VEGFD PDZRN4 COL6A6 MAP1LC3C ADGRG2 TENM1	2.87e-05	188	207	7	0e2d1b21f0a7ee306e7dae16fc8c19d16a467883
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE FAP FNDC1 CPQ UGP2 VEGFD DDR2	2.97e-05	189	207	7	6e52cac679e0541ca5f2be316bdabdbc34da6e18
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	F8 RIN2 SYNE2 ADGRF5 VEGFC HSPG2 SLC14A1	2.97e-05	189	207	7	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	MYO7B SLCO2B1 ADA2 ERAP2 CCR1 DOCK2 ARHGEF10L	2.97e-05	189	207	7	c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RNF130 FBXL5 VMP1 PARP14 CTSA RGS2 SLC2A3	2.97e-05	189	207	7	cce6602ad68c177985a5e43cfb2776d615cfbca0
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FAP FNDC1 COL14A1 PDZRN4 COL6A6 DDR2 ADGRG2	2.97e-05	189	207	7	40764f461b8aa1d3a2c5a30590b7fb9307d47d09
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	RNF130 RIPOR2 NLRC4 DOCK2 VMP1 RGS2 TBC1D8	2.97e-05	189	207	7	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FAP FNDC1 COL14A1 PDZRN4 COL6A6 DDR2 ADGRG2	2.97e-05	189	207	7	eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0
Drug	Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	NOL10 TNFSF4 CPQ COL14A1 TLN2 DOP1B CACNA1F HSPG2 SLC2A3 SLC15A1 CNTNAP2 TENM1	2.31e-07	197	204	12	4120_UP
Drug	cis-MCG-I	GRM3 GRM4 GRM5 GRM7	4.26e-07	8	204	4	CID003035584
Drug	mM PEP	GRM3 GRM4 GRM5 GRM7	7.61e-07	9	204	4	CID005311462
Drug	AC1N21PP	GRM3 GRM4 GRM5 GRM7	7.61e-07	9	204	4	CID004014619
Drug	1,3-cyclopentanedicarboxylic acid	GRM3 GRM4 GRM5 GRM7	7.61e-07	9	204	4	CID000107216
Drug	carbachol	ADCY10 RNF130 MYH6 TRPC4 TRPC5 BCHE CHRM1 CHRM5 RYR3 MYO5C KCNMB1 KCNN1 CACNA1F GRM3 PKD1L3 GRM4 GRM5 GRM7 RGS2 CACNA2D4 PKN2	1.09e-06	688	204	21	CID000002551
Drug	NS-105	GRM3 GRM4 GRM5 GRM7	1.26e-06	10	204	4	CID000198695
Drug	ibotenic acid	BCHE ACE CHRM1 GPSM2 GRM3 GRM4 GRM5 GRM7 CLCA2	1.59e-06	122	204	9	CID000001233
Drug	cyclobutylene AP5	GRM3 GRM4 GRM5 GRM7	1.97e-06	11	204	4	CID000126582
Drug	RS)-2-chloro-5-hydroxyphenylglycine	NFX1 GRM3 GRM4 GRM5 GRM7	2.03e-06	24	204	5	CID003645780
Drug	verapamil	ADCY10 MYH6 ACE CHRM1 TBC1D9 RYR3 KCNMB1 KCNN1 ABCC2 VEGFC CACNA1F ABCC9 APOB PKD1L3 LEP CACNA2D4 PKN2	2.23e-06	490	204	17	CID000002520
Drug	AC1MMZLG	STK38 F8 FAP ANAPC2 COL14A1 CTNNA3 CTNNA1	2.31e-06	67	204	7	CID003269220
Drug	AC1NQH9B	VEGFC GRM3 GRM4 GRM5 GRM7	3.10e-06	26	204	5	CID005221504
Drug	Mspg	GRM3 GRM4 GRM5 GRM7	4.20e-06	13	204	4	CID003964410
Drug	MSOPPE	GRM3 GRM4 GRM5 GRM7	4.20e-06	13	204	4	CID005311463
Drug	AC1NSKBB	GRM3 GRM4 GRM5 GRM7	4.20e-06	13	204	4	CID005311256
Drug	nifedipine	MYH6 TRPC5 ACE CHRM1 TBC1D9 RYR3 COL14A1 CACNA1F GRM3 PKD1L3 GRM4 GRM5 GRM7 CACNA2D4 CYP4F12	5.51e-06	415	204	15	CID000004485
Drug	MTPG	GRM3 GRM4 GRM5 GRM7	5.84e-06	14	204	4	CID005311456
Drug	2-methyl-6-styrylpyridine	GRM3 GRM4 GRM5 GRM7	5.84e-06	14	204	4	CID000235382
Drug	DE gel	PER3 GPSM2 VEGFC GRM3 GRM4 GRM5 GRM7 LEP CACNA2D4	5.90e-06	143	204	9	CID000008146
Drug	F 2268	BCHE CHRM1 CHRM5	7.00e-06	5	204	3	CID000020410
Drug	baclofen	ADCY10 DPYSL5 RYR3 CACNA1F GRM3 PKD1L3 GRM4 GRM5 GRM7 CACNA2D4	9.19e-06	191	204	10	CID000002284
Drug	ethylglutamate	GRM3 GRM4 GRM5 GRM7	1.05e-05	16	204	4	CID000014241
Drug	2-PMPA	GRM3 GRM4 GRM5 GRM7	1.05e-05	16	204	4	CID010130754
Drug	AC1L1KS5	TRPC5 CHRM1 RYR3 CACNA1F GRM3 PKD1L3 GRM4 GRM5 GRM7 RGS2 CACNA2D4 SLC14A1 PLPP2	1.08e-05	334	204	13	CID000005631
Drug	Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	IL16 RIPOR2 ACE TBC1D9 ABCC9 CLCA2 PLPP2 SLC15A1 ACOT11 SLCO2A1	1.10e-05	195	204	10	3800_UP
Drug	CPPG	VEGFC GRM3 GRM4 GRM5 GRM7	1.24e-05	34	204	5	CID000002878
Drug	gadolinium	TRPC5 F8 RYR3 CPQ CACNA1F GRM3 PKD1L3 CTSA CACNA2D4 PKD2L2	1.31e-05	199	204	10	CID000023982
Drug	3HPG	GRM3 GRM4 GRM5 GRM7	1.36e-05	17	204	4	CID000001217
Drug	1m5d	COPS2 GRM3 GRM4 GRM5 GRM7	1.43e-05	35	204	5	CID000447082
Drug	D-myo-inositol-1,4,5-triphosphate	RNF130 TRPC4 TRPC5 ACE CHRM1 RYR3 BHLHA15 CACNA1F GRM3 PKD1L3 GRM4 GRM5 GRM7 RGS2 CACNA2D4 PLPP2 PKN2	1.55e-05	568	204	17	CID000000806
Drug	acromelic acid A	GRM3 GRM4 GRM5 GRM7	1.74e-05	18	204	4	CID000108086
Drug	AC1L1DXE	TRPC4 TRPC5 BCHE CHRM1 RYR3 VEGFC FLII CACNA1F PKD1L3 LEP CACNA2D4 PKN2	1.75e-05	299	204	12	CID000002548
Drug	aminocyclopentane	GRM3 GRM4 GRM5 GRM7	2.18e-05	19	204	4	CID000002906
Drug	4-carboxy-3-hydroxyphenylglycine	GRM3 GRM4 GRM5 GRM7	2.71e-05	20	204	4	CID000001297
Drug	riluzole	RYR3 KCNN1 CACNA1F GRM3 PKD1L3 GRM4 GRM5 GRM7 CACNA2D4	2.85e-05	174	204	9	CID000005070
Drug	1,2-diglyceride	CHRM1 NFX1 GRM3 GRM4 GRM5 GRM7 SLC2A3 PLPP2 PKN2	2.98e-05	175	204	9	CID000192866
Drug	eye gene	ADCY10 MYH6 MYO1A MYO9A ACE CHRM1 MYO5C KCNN1 MYO1B RGS2 LEP CACNA2D4 PKN2	3.07e-05	369	204	13	CID000004782
Drug	AC1NNRU4	NFX1 GRM3 GRM4 GRM5 GRM7	3.17e-05	41	204	5	CID005126051
Drug	lanthanum	TRPC4 TRPC5 RYR3 CACNA1F PKD2L1 PKD1L3 CACNA2D4 PKD2L2	3.20e-05	136	204	8	CID000023926
Drug	3,4-dihydroxyphenylglycine	GRM3 GRM4 GRM5 GRM7	3.32e-05	21	204	4	CID000027915
Drug	butenafine	VEGFC GRM3 GRM4 GRM5 GRM7	3.57e-05	42	204	5	CID000002484
Drug	2,4,5,2',5'-pentachlorobiphenyl	ADCY10 KNTC1 INPP4A STK38 ACOT4 UBN2 CSMD3 STK35 CHRM1 FNDC1 SYNE2 TLN2 ADGRF5 RASSF3 ABCC2 VEGFD CACNA1F INTS7 KNSTRN SMCHD1 DDR2 MYO1B PARP14 GRM5 LEP FRY HASPIN CNTNAP2 CATSPERG	3.67e-05	1441	204	29	ctd:C009828
Drug	aceclidine	BCHE CHRM1 CHRM5	3.84e-05	8	204	3	CID000001979
Drug	potassium	MYO1A FBP2 ACE CHRM1 RYR3 KCNMB1 KCNN1 CACNA1F ABCC9 MYO1B GRM3 PKD1L3 GRM4 GRM5 GRM7 LEP CACNA2D4 CLCA2 SLC14A1 CNTNAP2 PKN2 ATP1A4 SLC12A7	3.89e-05	1008	204	23	CID000000813
Drug	Digocin	SLCO2B1 ACE TBC1D9 ABCC2 DSG1 SLCO2A1	3.91e-05	70	204	6	CID000003062
Drug	glibenclamide	SLCO2B1 FBP2 ACE CHRM1 TBC1D9 KCNMB1 KCNN1 ABCC2 ABCC9 APOB LEP CACNA2D4 CLCA2	4.39e-05	382	204	13	CID000003488
Drug	norbiotin	FLII GRM3 GRM4 GRM5 GRM7 CTBS	4.59e-05	72	204	6	CID000446903
Drug	MSOP	GRM3 GRM4 GRM5 GRM7	4.85e-05	23	204	4	CID003964633
Drug	caffeine	MYH6 PDE8A CHRM1 RYR3 DNASE1 CACNA1F GRM3 PKD1L3 GRM4 GRM5 GRM7 CACNA2D4 PKD2L2 ACOT11 CYP4F12 CNOT1	5.04e-05	562	204	16	CID000002519
Drug	nimodipine	RYR3 CACNA1F GRM3 PKD1L3 GRM4 GRM5 GRM7 CACNA2D4	5.05e-05	145	204	8	CID000004497
Drug	Dantrolene-13C3	RYR3 CACNA1F GRM3 PKD1L3 GRM4 GRM5 GRM7 CACNA2D4	5.05e-05	145	204	8	CID000002951
Drug	Parathion	ABL1 DPYSL5 BCHE CAMTA2 COL14A1 HSD17B3 VEGFC DNAH3 PCDHGB7 DUSP6 PKD2L1 GRM7 RFX4 LEP CLCA2 SLC15A1 ACOT11 CNTNAP2 ATP1A4 CFAP46	5.33e-05	822	204	20	ctd:D010278
Drug	cysteine sulfinic acid	PRRX2 GRM3 GRM4 GRM5 GRM7	5.59e-05	46	204	5	CID000000109
Drug	deme	CHRM1 NFX1 SAGE1 CTSA LHCGR	5.59e-05	46	204	5	CID000152803
Drug	methylfurmethide	BCHE CHRM1 CHRM5	5.72e-05	9	204	3	CID000004141
Drug	sila-hexocyclium	BCHE CHRM1 CHRM5	5.72e-05	9	204	3	CID000130169
Drug	Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A	ADCY10 CCR1 ADGRF5 FAT4 APOB TEX14 GRM7 RGS2 FRY	6.39e-05	193	204	9	2283_UP
Drug	2,4,4'-trichlorobiphenyl	ADCY10 KNTC1 INPP4A STK38 ACOT4 UBN2 CSMD3 STK35 CHRM1 FNDC1 SYNE2 TLN2 ADGRF5 RASSF3 ABCC2 VEGFD CACNA1F INTS7 KNSTRN SMCHD1 DDR2 MYO1B PARP14 GRM5 FRY HASPIN CNTNAP2 CATSPERG	6.47e-05	1411	204	28	ctd:C081766
Drug	Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; HL60; HT_HG-U133A	RIPOR2 NOL10 RYR3 NR0B1 COL14A1 TLN2 KRT23 ADGRG2 SLC12A7	6.92e-05	195	204	9	3001_UP
Drug	Nadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A	IL16 SLCO2B1 CHRM5 ADGRF5 TEX14 KRT23 SLCO2A1 CNTNAP2 DNAI4	7.49e-05	197	204	9	6091_UP
Drug	Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; PC3; HT_HG-U133A	RIPOR2 INPP4A SLC35C1 BCHE KCNN1 COL14A1 MYO1B GRM7 SLC15A1	7.49e-05	197	204	9	4078_UP
Drug	Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; PC3; HT_HG-U133A	SLCO2B1 COL14A1 TLN2 DOP1B HSPG2 PKD2L2 SLC15A1 ACOT11 CNTNAP2	7.78e-05	198	204	9	4230_UP
Drug	isocamphane	SYNE2 SAGE1	7.99e-05	2	204	2	CID000296894
Drug	Lisdexamfetamine Dimesylate	LEP SLC15A1	7.99e-05	2	204	2	ctd:D000069478
Drug	NIK-247	BCHE CHRM1 LEP	8.12e-05	10	204	3	CID000604519
Drug	Fonofos	DPYSL5 CAMTA2 COL14A1 HSD17B3 VEGFC DNAH3 PCDHGB7 DUSP6 PKD2L1 GRM7 RFX4 LEP CLCA2 SLC15A1 ACOT11 CNTNAP2 ATP1A4 CFAP46	8.18e-05	714	204	18	ctd:D004397
Drug	cyclizine	KNTC1 CHRM1 ANAPC2 GRM3 GRM4 GRM5 GRM7	8.55e-05	116	204	7	CID000006726
Drug	B0683	MYH6 MYO1A MYO9A BCHE MYO5C FAP MYO1B	9.02e-05	117	204	7	CID006398969
Drug	GTP[S]	RNF130 MYO1A TRPC5 SSTR4 CHRM1 RYR3 GPSM2 GRM3 PKD1L3 GRM4 GRM5 GRM7 RGS2 CACNA2D4 PLPP2 PKN2	9.08e-05	591	204	16	CID000001764
Drug	N-methyl-DL-aspartic acid	TRPC5 BCHE CHRM1 RYR3 NFX1 GPSM2 VEGFC FLII CACNA1F GRM3 PKD1L3 GRM4 GRM5 GRM7 LEP CACNA2D4 PKN2	9.13e-05	655	204	17	CID000004376
Drug	formycin triphosphate	MYH6 MYO1A MYO9A MYO5C MYO1B	9.24e-05	51	204	5	CID000122274
Drug	chelerythrine	IL16 TRPC5 CHRM1 TYK2 GRM3 GRM4 GRM5 GRM7 LEP CACNA2D4 PKN2 SLC12A7	9.71e-05	357	204	12	CID000002703
Drug	terbufos	DPYSL5 CAMTA2 COL14A1 HSD17B3 VEGFC DNAH3 PCDHGB7 DUSP6 PKD2L1 GRM7 RFX4 LEP CLCA2 SLC15A1 ACOT11 CNTNAP2 ATP1A4 CFAP46	9.74e-05	724	204	18	ctd:C012568
Drug	cyclopentolate	BCHE CHRM1 CHRM5	1.11e-04	11	204	3	CID000002905
Drug	N-Ac-D-E	GPSM2 GRM3 GRM4 GRM5 GRM7	1.11e-04	53	204	5	CID000005255
Drug	isoproterenol	ADCY10 RNF130 MYH6 PDE8A MYO1A MYO9A ACE CHRM1 RYR3 MYO5C CACNA1F ABCC9 MYO1B LEP CACNA2D4 CLCA2 PKN2	1.18e-04	669	204	17	CID000003779
Drug	2gst	RNF130 ADGRF5 PKD2L1 PKD1L3 ADGRG2 SLIT1	1.25e-04	86	204	6	CID000444461
Drug	IPSP	GPSM2 GRM3 GRM4 GRM5 GRM7 LEP	1.33e-04	87	204	6	CID000022083
Drug	2-phenylglycine	GRM3 GRM4 GRM5 GRM7 CNTNAP2	1.33e-04	55	204	5	CID000003866
Drug	PBDA	GRM3 GRM4 GRM5 GRM7	1.43e-04	30	204	4	CID000004408
Drug	Cinildipine	ACE RYR3 CACNA1F PKD1L3 CACNA2D4	1.45e-04	56	204	5	CID000002752
Drug	AP-5	CHRM1 VEGFC GRM3 GRM4 GRM5 GRM7 CACNA2D4	1.58e-04	128	204	7	CID000001216
Drug	2-amino-4-phosphonobutyric acid	GPSM2 VEGFC GRM3 GRM4 GRM5 GRM7	1.70e-04	91	204	6	CID000002207
Drug	GYKI 52466	ABCC9 GRM3 GRM4 GRM5 GRM7	1.71e-04	58	204	5	CID000003538
Drug	purealin	MYH6 MYO1A MYO9A MYO5C MYO1B	1.71e-04	58	204	5	CID006419303
Drug	Vanadium	ABL1 SLCO2B1 STK38 VEGFD CACNA1F LEP SLC15A1 SLC12A7	1.73e-04	173	204	8	ctd:D014639
Drug	BAPTA	TRPC4 TRPC5 CHRM1 RYR3 FAP GRM3 GRM4 GRM5 GRM7 RGS2 CACNA2D4	1.74e-04	324	204	11	CID000104751
Drug	alpha-methyl-4-carboxyphenylglycine	GRM3 GRM4 GRM5 GRM7	1.85e-04	32	204	4	CID000001222
Drug	indole-3-propionic acid	CUL1 UBA3 SLC14A1	1.90e-04	13	204	3	CID000003744
Drug	ambenonium	BCHE ACE CHRM1	1.90e-04	13	204	3	CID000002131
Drug	nilvadipine	ACE RYR3 CACNA1F PKD1L3 CACNA2D4	2.01e-04	60	204	5	CID000004494
Drug	CNS 1145	RYR3 CACNA1F PKD1L3 CACNA2D4	2.09e-04	33	204	4	CID000190902
Drug	IHC-64	RYR3 CACNA1F PKD1L3 CACNA2D4	2.09e-04	33	204	4	CID000162753
Drug	1-aminoindan-1,5-dicarboxylic acid	GRM3 GRM4 GRM5 GRM7	2.09e-04	33	204	4	CID000002071
Drug	manidipine	MYH6 ACE RYR3 CACNA1F PKD1L3 CACNA2D4	2.15e-04	95	204	6	CID000004008
Drug	menthol glucuronide	UGP2 APOB	2.38e-04	3	204	2	CID000133208
Drug	RU 47213	BCHE CHRM1	2.38e-04	3	204	2	CID009571042
Drug	1,2-dihydroxypropylphosphonic acid	RNF130 CHRM1	2.38e-04	3	204	2	CID009543358
Drug	RU 35963	BCHE CHRM1	2.38e-04	3	204	2	CID009578335
Disease	1-stearoylglycerol 1-monostearin measurement	SYNE2 KIAA1549	4.62e-05	2	201	2	EFO_0021111
Disease	Bipolar Disorder	BCHE ACE TAAR6 PER3 STARD9 DUSP6 GRM3 GRM4 GRM5 GRM7 RFX4 CNTNAP2	1.15e-04	477	201	12	C0005586
Disease	Seizures	BCHE CHRM1 HACE1 UGP2 ABCC2 PIGB LEP EIF3F	1.32e-04	218	201	8	C0036572
Disease	gallbladder adenocarcinoma (is_implicated_in)	ACE DDR2	1.38e-04	3	201	2	DOID:3500 (is_implicated_in)
Disease	polycystic kidney disease 2 (implicated_via_orthology)	PKD2L1 PKD2L2	1.38e-04	3	201	2	DOID:0110859 (implicated_via_orthology)
Disease	alcoholic liver cirrhosis (implicated_via_orthology)	DDR2 LEP	1.38e-04	3	201	2	DOID:14018 (implicated_via_orthology)
Disease	disease free survival	CCDC168 CHRM1 CNTNAP2	2.36e-04	18	201	3	EFO_0000409
Disease	nephrotic syndrome type 20 (implicated_via_orthology)	TBC1D9 TBC1D8	2.75e-04	4	201	2	DOID:0070357 (implicated_via_orthology)
Disease	electrocardiography	MYH6 RIPOR2 DPYSL5 RAB29 VEGFC INTS7 DDR2 OR8B8 RADIL CTNNA3 CNTNAP2 CNOT1	3.02e-04	530	201	12	EFO_0004327
Disease	Malignant neoplasm of breast	ABL1 SLCO2B1 TRPC4 MCF2L2 BCHE PER3 SYNE2 VEGFC EHBP1 HELQ RGS2 LEP EPG5 LHCGR CLCA2 TENM1 ZFYVE26 CPSF3	4.26e-04	1074	201	18	C0006142
Disease	Hermaphroditism	HSD17B3 LHCGR	4.56e-04	5	201	2	C0019269
Disease	Ambiguous Genitalia	HSD17B3 LHCGR	4.56e-04	5	201	2	C0266362
Disease	quality of life during menstruation measurement, Arthralgia	DOP1B CACNA2D4	4.56e-04	5	201	2	EFO_0009366, HP_0002829
Disease	Pseudohermaphroditism	HSD17B3 LHCGR	4.56e-04	5	201	2	C0033804
Disease	Intersex Conditions	HSD17B3 LHCGR	4.56e-04	5	201	2	C2930618
Disease	Sex Differentiation Disorders	HSD17B3 LHCGR	4.56e-04	5	201	2	C2930619
Disease	Epilepsy, Benign Psychomotor, Childhood	GRM3 GRM4 GRM5	4.99e-04	23	201	3	C0393672
Disease	Epilepsy, Lateral Temporal	GRM3 GRM4 GRM5	4.99e-04	23	201	3	C0393682
Disease	Uncinate Epilepsy	GRM3 GRM4 GRM5	4.99e-04	23	201	3	C0014558
Disease	Epilepsy, Temporal Lobe	GRM3 GRM4 GRM5	4.99e-04	23	201	3	C0014556
Disease	ecosanoids measurement	ACOT4 ABCC2 PKD2L1 ACKR4	5.43e-04	55	201	4	EFO_0020044
Disease	stearoyl sphingomyelin (d18:1/18:0) measurement	CAMTA2 SYNE2	6.80e-04	6	201	2	EFO_0800611
Disease	Abnormality of vision	UGP2 PIGB	6.80e-04	6	201	2	C4025846
Disease	Hallux valgus	HACE1 MYO1B CLCA2 SLIT1	7.56e-04	60	201	4	HP_0001822
Disease	LDL cholesterol change measurement	APOB PKD1L3	9.48e-04	7	201	2	EFO_0007804
Disease	Arima syndrome	TMEM237 TMEM138	9.48e-04	7	201	2	C1855675
Disease	Disorders of Sex Development	HSD17B3 LHCGR	9.48e-04	7	201	2	C0036875
Disease	bilirubin measurement	MGAT4D UBR1 ABL1 PIEZO1 ABCC2 RAB29 FAT4 ABCC9 APOB PKN2	9.62e-04	442	201	10	EFO_0004570
Disease	hypertension (biomarker_via_orthology)	ACE KCNMB1 HSPG2 ABCC9 RGS2 SLC2A3 CYP4F12	9.76e-04	227	201	7	DOID:10763 (biomarker_via_orthology)
Disease	Drug habituation	CSMD3 MYO5C GRM5 GRM7 CTNNA3	1.17e-03	115	201	5	C0013170
Disease	Drug abuse	CSMD3 MYO5C GRM5 GRM7 CTNNA3	1.17e-03	115	201	5	C0013146
Disease	Prescription Drug Abuse	CSMD3 MYO5C GRM5 GRM7 CTNNA3	1.17e-03	115	201	5	C4316881
Disease	Substance-Related Disorders	CSMD3 MYO5C GRM5 GRM7 CTNNA3	1.17e-03	115	201	5	C0236969
Disease	Drug Use Disorders	CSMD3 MYO5C GRM5 GRM7 CTNNA3	1.17e-03	115	201	5	C0013222
Disease	Drug Dependence	CSMD3 MYO5C GRM5 GRM7 CTNNA3	1.17e-03	115	201	5	C1510472
Disease	Substance Dependence	CSMD3 MYO5C GRM5 GRM7 CTNNA3	1.17e-03	115	201	5	C0038580
Disease	Substance Use Disorders	CSMD3 MYO5C GRM5 GRM7 CTNNA3	1.17e-03	115	201	5	C0038586
Disease	Organic Mental Disorders, Substance-Induced	CSMD3 MYO5C GRM5 GRM7 CTNNA3	1.17e-03	115	201	5	C0029231
Disease	Substance abuse problem	CSMD3 MYO5C GRM5 GRM7 CTNNA3	1.21e-03	116	201	5	C0740858
Disease	fatty liver disease (biomarker_via_orthology)	ABCC2 APOB LEP	1.46e-03	33	201	3	DOID:9452 (biomarker_via_orthology)
Disease	Chronic schizophrenia	ACE LEP	1.61e-03	9	201	2	C0221765
Disease	cytochrome p450 3a4 measurement	BCHE APOB	2.44e-03	11	201	2	EFO_0020303
Disease	hyperhomocysteinemia (implicated_via_orthology)	BCHE F8	2.44e-03	11	201	2	DOID:9279 (implicated_via_orthology)
Disease	Alcoholic Intoxication, Chronic	ACE PER3 GRM3 GRM7 RFX4 LEP CNTNAP2	2.51e-03	268	201	7	C0001973
Disease	psoriasis	TYK2 FAP ERAP2 SYNE2 SPATA31C2 AP5B1 SLIT1	2.78e-03	273	201	7	EFO_0000676
Disease	Parkinson Disease, Secondary Vascular	BCHE RGS2	2.91e-03	12	201	2	C0751414
Disease	Atherosclerotic Parkinsonism	BCHE RGS2	2.91e-03	12	201	2	C0751415
Disease	Secondary Parkinson Disease	BCHE RGS2	2.91e-03	12	201	2	C0030569
Disease	nicotine dependence (implicated_via_orthology)	TRPC4 TRPC5	2.91e-03	12	201	2	DOID:0050742 (implicated_via_orthology)
Disease	integral membrane protein 2B measurement	BCHE APOB	2.91e-03	12	201	2	EFO_0802634
Disease	Alzheimer disease, dementia	RFX4 CFAP46	2.91e-03	12	201	2	MONDO_0001627, MONDO_0004975
Disease	neutrophil count	RIPOR2 NUP210L TNFSF4 OTUD7B MED24 ERAP2 TLN2 ADGRF5 RASSF3 DNASE1 VMP1 IPO7 MYO1B TEX14 TBC1D8 GTF3C1 PKN2 ATP1A4 SLC12A7	2.98e-03	1382	201	19	EFO_0004833
Disease	Colorectal Carcinoma	MCF2L2 CSMD3 ABCC2 PDZRN4 DNAH3 WRN MYO1B APOB ARHGEF10L SLCO2A1 TENM1 SNRNP200	3.31e-03	702	201	12	C0009402
Disease	Crohn's disease of large bowel	TYK2 ERAP2 LEP	3.36e-03	44	201	3	C0156147
Disease	IIeocolitis	TYK2 ERAP2 LEP	3.36e-03	44	201	3	C0949272
Disease	Crohn's disease of the ileum	TYK2 ERAP2 LEP	3.36e-03	44	201	3	C0267380
Disease	Regional enteritis	TYK2 ERAP2 LEP	3.36e-03	44	201	3	C0678202
Disease	interleukin 6 receptor subunit alpha measurement	NUP210L OTUD7B	3.43e-03	13	201	2	EFO_0008187
Disease	Depressed mood	ACE TYK2	3.43e-03	13	201	2	C0344315
Disease	urate measurement	RIPOR2 MYO9A DPYSL5 CHRM1 DNASE1 PDZRN4 VMP1 DNAH3 INTS7 DDR2 TEX14 TBC1D8 CACNA2D4 AP5B1	3.45e-03	895	201	14	EFO_0004531
Disease	obesity (implicated_via_orthology)	TYK2 HSD17B3 FLII FAT4 LEP SLC15A1	3.66e-03	215	201	6	DOID:9970 (implicated_via_orthology)
Disease	response to paliperidone, schizophrenia symptom severity measurement	CSMD3 FAP KIAA1549 EPG5 CTNNA3 EIF3F	3.74e-03	216	201	6	EFO_0007925, EFO_0007927
Disease	coronary artery calcification	ABL1 STARD9 DSG1 APOB GRM5 GRM7 RGS2 FRY CLCA2	3.89e-03	450	201	9	EFO_0004723
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD2L1 PKD2L2	3.98e-03	14	201	2	DOID:898 (implicated_via_orthology)
Disease	beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement	HSD17B3 FAT4	3.98e-03	14	201	2	EFO_0004670, EFO_0006794
Disease	unipolar depression, bipolar disorder	STARD9 SYNE2 VEGFC FAT4 GRM5	4.39e-03	156	201	5	EFO_0003761, MONDO_0004985
Disease	Hypogonadotropic hypogonadism	NR0B1 LEP	4.57e-03	15	201	2	C0271623
Disease	triacylglycerol 52:3 measurement	PKD2L1 APOB	4.57e-03	15	201	2	EFO_0010415
Disease	Hypertriglyceridemia	BCHE APOB	4.57e-03	15	201	2	C0020557
Disease	Primary hypogonadism	NR0B1 LEP	4.57e-03	15	201	2	C0948896
Disease	Hypogonadism, Isolated Hypogonadotropic	NR0B1 LEP	4.57e-03	15	201	2	C3489396
Disease	Crohn Disease	TYK2 ERAP2 LEP	4.82e-03	50	201	3	C0010346
Disease	Atrial Fibrillation	MYH6 ACE SYNE2 HSPG2 ABCC9	4.89e-03	160	201	5	C0004238
Disease	coronary artery disease (is_implicated_in)	BCHE ACE WRN APOB	4.93e-03	100	201	4	DOID:3393 (is_implicated_in)
Disease	Generalized seizures	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0234533
Disease	Clonic Seizures	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0234535
Disease	Convulsive Seizures	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0751494
Disease	Seizures, Sensory	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0751496
Disease	Non-epileptic convulsion	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0751056
Disease	Atonic Absence Seizures	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0751123
Disease	Complex partial seizures	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0149958
Disease	Single Seizure	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0751110
Disease	Nonepileptic Seizures	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C3495874
Disease	Visual seizure	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0270824
Disease	Epileptic drop attack	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0270846
Disease	Vertiginous seizure	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0422855
Disease	Gustatory seizure	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0422854
Disease	Seizures, Somatosensory	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0422850
Disease	Olfactory seizure	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0422853
Disease	Seizures, Auditory	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0422852
Disease	Generalized Absence Seizures	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C4505436
Disease	Jacksonian Seizure	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C0022333
Disease	Epileptic Seizures	BCHE CHRM1 ABCC2 LEP	5.10e-03	101	201	4	C4317109
Disease	myeloid white cell count	ABL1 PIEZO1 FAP TLN2 ADGRF5 RASSF3 DNASE1 VMP1 MYO1B TBC1D8 GTF3C1 PKN2 ATP1A4 SLC12A7	5.14e-03	937	201	14	EFO_0007988
Disease	Hypogonadism	NR0B1 LEP	5.20e-03	16	201	2	C0020619
Disease	triacylglycerol 50:5 measurement	MYO1B CACNA2D4	5.20e-03	16	201	2	EFO_0010412
Disease	Absence Seizures	BCHE CHRM1 ABCC2 LEP	5.28e-03	102	201	4	C4316903
Disease	Convulsions	BCHE CHRM1 ABCC2 LEP	5.28e-03	102	201	4	C4048158
Disease	Tonic Seizures	BCHE CHRM1 ABCC2 LEP	5.28e-03	102	201	4	C0270844
Disease	Weight Gain	ACE KCNMB1 MYO1B LEP	5.28e-03	102	201	4	C0043094

Protein segments in the cluster

Peptide	Gene	Start	Entry
SLKLMQQSSLYASNE	CATSPERG	561	Q6ZRH7
KQQLASLVGTMLAYS	CHTF18	786	Q8WVB6
SESMKQVSYLASIVR	EPG5	941	Q9HCE0
LNALESMASSKQYVE	EPG5	2521	Q9HCE0
SAMKNLLKYSSQALV	BAHCC1	631	Q9P281
SDYVNNFTSAMSIIK	ARHGEF10L	411	Q9HCE6
QKYLTLNTESTRIMT	BCHE	526	P06276
AMLAKQSTSKVQVLY	DISP3	431	Q9P2K9
KVNISNYSLVMESDA	CPQ	351	Q9Y646
TYIQAMLTNLESLSL	ANAPC2	756	Q9UJX6
TLSNSNMELLLSGVY	CSMD3	3531	Q7Z407
SINSILDYISTSKQM	COPS2	111	P61201
SNYTDLAMSTVKQTQ	CPSF3	501	Q9UKF6
LAMSTVKQTQAIPYT	CPSF3	506	Q9UKF6
NALLSNMSRIYSTAK	ACE	141	P12821
NVKDSSMLISLTYDV	GRM3	731	Q14832
LGMSISYAALLTKTN	GRM4	661	Q14833
SASTMDLNSNISYLI	FAT4	816	Q6V0I7
LNKTLQTLSETYFIM	ADGRG2	161	Q8IZP9
KNYIKSLTATILTMS	BHLHA15	121	Q7RTS1
KNSISLSVTFYINML	CFAP46	236	Q8IYW2
MTQAAILIQSKFRSY	CAMTA2	1101	O94983
YLSYNNVSSLKMLVA	ACOT11	386	Q8WXI4
IYNKILRLSTSNLSM	ABCC9	391	O60706
KKFLISNSSQVLMYE	ADCY10	501	Q96PN6
IMLKELNSYSSALSQ	CCDC180	616	Q9P1Z9
YKTIMKQINSSISGN	CTBS	291	Q01459
QLKTSISSQYVIRMQ	DTWD2	201	Q8NBA8
SAVEYAQSQLSLVSM	PDZRN4	861	Q6ZMN7
LAMNQGKVSSLFYTT	OR8B8	266	Q15620
AVLIQTVYNTKMASV	HSPG2	691	P98160
YNLAVTDKLKMTLNS	RASSF3	61	Q86WH2
IMSLSTQGDYINLQT	RAB29	181	O14966
NSITKQTLYTMEDSR	RFX4	356	Q33E94
LSYLEKNISVQMTIA	RNF130	166	Q86XS8
MAKELYQSLLTQVAS	INTS7	541	Q9NVH2
DSLINQMTQVKLSVY	INPP4A	106	Q96PE3
MLASRSASLLKSYSQ	PRRX2	166	Q99811
DISMNSLSKYQLSPN	PCDHGB7	161	Q9Y5F8
AMVKSNQYLSILAAQ	KCNMB1	176	Q16558
NLSLYSMELVLKKST	KIAA1549	71	Q9HCM3
VSRLKSLTYMSINYN	LRRC69	126	Q6ZNQ3
SQLLSSMLSRTLSYK	RADIL	21	Q96JH8
MCKITSALYTLNFVS	ACKR4	111	Q9NPB9
SKYSQEVMQSLSILR	OTUD7B	586	Q6GQQ9
SLSNLVASLLNSMKS	CACNA1F	641	O60840
ITSMLNSLIYSLRNK	OR2B3	281	O76000
SKNSLYLQMNSLKTE	IGHV3-72	96	A0A0B4J1Y9
LNTMFDTSYSKQVIN	FLII	1121	Q13045
LQMVLGLSYSTNNSI	GPSM2	371	P81274
AMSYSALVTKTNRIA	GRM5	656	P41594
VNNKTLYSSMLAESE	LHCGR	311	P22888
QKQLRQTAATYMLTA	MED14OS	81	P0DP75
NGYLQKMVSISDITS	NLRC4	471	Q9NPP4
SKNTLYLQMNSLKTE	IGHV3-15	96	A0A0B4J1V0
QFKSSVAILMKNLYS	MYO1A	566	Q9UBC5
TVSYTNLKFMATQIA	DDR2	681	Q16832
QLSTIRSFLKLYTTM	EIF3L	456	Q9Y262
STSKNQLYSITMSLT	CFAP57	356	Q96MR6
FVLLSLSASMYTSQK	DOP1B	1386	Q9Y3R5
ANTLTDLAKTQTVMY	KCNN1	451	Q92952
EFSLNTQMYLLSKKS	FREM2	2856	Q5SZK8
ILIKNYSDSLTAAMI	CAND1	676	Q86VP6
VLSNSLVINMVQSSY	FBP2	76	O00757
FALTLKTTAQMLQTF	MCF2L2	206	Q86YR7
NLGQQLYIESMTKSS	PER3	471	P56645
KSLNFVSTLLQITMS	IPO7	31	O95373
NADVKNVYMLATTVS	PGM2L1	376	Q6PCE3
YVLSTKNTQMVSSNI	PDE8A	461	O60658
LLSLSSNYDAQMKSL	HACE1	306	Q8IYU2
KLYSISSQVSSAVMK	IL16	986	Q14005
STYQRIAAISMASKI	NFX1	906	Q12986
LQTQYSTKSALENML	KRT23	301	Q9C075
TLSKMDQTLAVYQQI	LEP	71	P41159
SIGQMTSLLYLNVSN	LRRC18	91	Q8N456
SLLNSMSASVSLQKL	KNTC1	586	P50748
LLSSTLVYNSMGTIN	GBP3	121	Q9H0R5
IMASVYKKALTLSNL	ABCC2	396	Q92887
LTSMYVKEFLISSSQ	F8	2271	P00451
SEQTKVSLLALSMEY	AP5B1	46	Q2VPB7
MQVSSLNEVKIYSLS	NOL10	1	Q9BSC4
AAVSQSLTDLAKYMI	PLPP2	106	O43688
SKSIAYLQMNSLKTE	IGHV3-49	96	A0A0A0MS15
VNLSYTVVAFTKQTM	EXOC8	611	Q8IYI6
IMSQYKLKASAISVT	DSG1	361	Q02413
KAAAYLSEAMKLTQS	NRBF2	36	Q96F24
SYLKQTLTSVVSRMT	MGAT4D	146	A6NG13
MLVNFLSETKTISYS	OR1L1	131	Q8NH94
SIYSLISLLKMQNRT	GPR149	51	Q86SP6
QGSILYSMLTSAKQT	NR0B1	76	P51843
LLYSTKMSTQVSVQL	OR5P2	126	Q8WZ92
SMNSQYLKLLSSQKY	CTSA	376	P10619
QKAMELVTINYSSDL	PAN3	711	Q58A45
LSSQQSVMSKLASFL	PARP14	1391	Q460N5
NAVVQTVKMSYIAST	CTNNA3	816	Q9UI47
TSISMVFLNKYLLDS	SLC35C1	51	Q96A29
YTRTTNLSSKLMEFN	EXOC5	311	O00471
FKYNRQSMTLSSEVQ	APOB	1051	P04114
LSTMISSIQVYNLSQ	ATL1	166	Q8WXF7
SINNLMKSQYKTTIL	DOCK2	776	Q92608
MNAVVQTVKASYVAS	CTNNA1	826	P35221
QSAAKLSTFMNAYEL	DNAH3	2441	Q8TD57
MVTYLANLTQSQIAL	EIF3F	336	O00303
KNMTSIYLLNLAISD	CCR1	66	P32246
YMDSKLLSSQAQSLT	CACNA2D4	491	Q7Z3S7
STVLKNLMSLTEYQI	COL14A1	406	Q05707
KNRYTLQASTFQMAI	CUL1	596	Q13616
TKMSNATLVSYIVQI	DNASE1	36	P24855
KLASESVYVVSLQSM	FNDC1	221	Q4ZHG4
KSYITIFNKSANIML	CYP4F12	161	Q9HCS2
VSLKTINAVQQMSLY	DPY19L4	126	Q7Z388
NAVVLLYMATQISSA	ABL1	336	P00519
YVASNASVMNLLLIS	CHRM1	106	P11229
TLKQLAMNSIKYSTL	ADA2	471	Q9NZK5
RKALATSSINMKQYA	EHBP1	111	Q8NDI1
MYLLSPLNTLSISNK	HASPIN	441	Q8TF76
YNAMELVSLSVKQSV	DNAI4	326	Q5VTH9
MSSAEQNKILYALST	ERAP2	816	Q6P179
STLMTVSLLLKDNYN	SLC2A3	346	P11169
EKLYIQTTTLTISMN	GRM7	816	Q14831
TQLVYSASMDQISAI	CNTNAP2	661	Q9UHC6
VLAYSSAVSSKMVRQ	FBXL5	336	Q9UKA1
ATSLVLNNLMYMTAK	FRY	1411	Q5TBA9
TSKSMIDKLLYNTAA	CCDC168	2216	Q8NDH2
YTSKTTQIIGMSATL	HELQ	486	Q8TDG4
VSTAMTKYLNTNVIT	HSD17B3	231	P37058
VTVTVAYLMQKLNLS	DUSP6	301	Q16828
MVSSLLNKLANYTNL	SLC12A7	81	Q9Y666
SYSQAPSNMKSVLQA	SLC15A1	606	P46059
LTSLVIMNQVSNAYL	CYB561D2	201	O14569
VAYSNETKVINSLSM	COL6A6	271	A6NMZ7
TSTYLMSLLANDTLN	DPYSL5	306	Q9BPU6
MLSYDLKTYLTNTLN	NUP210L	1561	Q5VU65
YLLVNNKSLVSMSAT	MAP1LC3C	86	Q9BXW4
SKNTAYLQMNSLKTE	IGHV3-73	96	A0A0B4J1V6
MNSVKYSSLVALAFI	PIGB	216	Q92521
IKLRSAMYLSNTTVT	TAS2R46	166	P59540
AMYLSNTTVTILANL	TAS2R46	171	P59540
SVKISYIGLMTQSSL	TMEM106C	221	Q9BVX2
TTAQKRVYSLMENNS	RGS2	171	P41220
TMTKVTLENFYSNLI	STK38	21	Q15208
SIVMYKSLFEASQQL	SMCHD1	1636	A6NHR9
NLNNMSTTEEYLISK	TEX14	721	Q8IWB6
RMLSYAASSQQATLK	SPATA31C2	1106	B4DYI2
MSSNSSLLVAVQLCY	TAAR6	1	Q96RI8
IYTNLSKMETVLGQS	SYNE2	3371	Q8WXH0
QMVSYSSVLTAISKF	MED24	71	O75448
LVTMTSVVKTVYSLQ	KNSTRN	76	Q9Y448
FLTLLMTAIYSAKNS	PKD1L3	1291	Q7Z443
IMSYITAKNSISVLD	STRIP1	621	Q5VSL9
AKMKTATNIYLLNLA	SSTR4	76	P31391
ITSNYKQQTGKLSMS	SHPRH	1166	Q149N8
MSTNLTATSTIYILK	TENM1	1696	Q9UKZ4
VNMASKILKSYESSL	ORC6	111	Q9Y5N6
SQSMAITYSLFQEKK	WRN	1256	Q14191
TMSTLRYASSAKNII	STARD9	371	Q9P2P6
MISTQNQYSTLSKPA	PKN2	311	Q16513
VVALYQKSSLKLMAT	MYH6	606	P13533
SYLSQLARQVSMVQT	RIPOR2	901	Q9Y4F9
YVASNASVMNLLVIS	CHRM5	111	P08912
MASFLKNVSATVSIN	ACOT4	241	Q8N9L9
IYTALFNNMTSVSKL	ADGRF5	321	Q8IZF2
DNLKKSIMYTLTSNI	ATP1A4	776	Q13733
QATSYEIRMSKSLQN	CLCA2	796	Q9UQC9
MNLDSLSLALSQISY	CNOT1	1	A5YKK6
LLMSISTNLKNSFAS	CNOT1	1461	A5YKK6
NINKLVLYTDSMFTI	RNASEH1	201	O60930
YFTALILSLSQQMTS	TMEM237	316	Q96Q45
NINMSSATSKQLIYL	SLCO2A1	476	Q92959
SYTILSNRTMKSVNA	FAP	86	Q12884
MLQTSNYSLVLSLQF	TMEM138	1	Q9NPI0
LDYLTNSASLQMKSP	UBA3	386	Q8TBC4
TDSQLKAMVQYAKSL	UHRF1BP1L	246	A0JNW5
MTQVKNYLSQSSELD	RIN2	561	Q8WYP3
KTTSDLLLVMSNLYS	UGP2	396	Q16851
TNKSFMLQLTSAIAF	STK35	336	Q8TDR2
SNYLAKAMVSQISTQ	UBN2	1011	Q6ZU65
LQCMNTSTSYLSKTL	VEGFC	171	P49767
MTSSVLTVNGKTENY	TMIGD1	26	Q6UXZ0
KVRSVNSLMVASLTY	TNFSF4	131	P23510
NLQMTYKLAITDLTT	TTC6	116	Q86TZ1
SMSTKDLYATVTQNV	SAGE1	521	Q9NXZ1
AQLMISGYLKSSIST	SLCO2B1	61	O94956
KNYNLQMSTETLKTL	RYR3	916	Q15413
YQLNSSRNMLTSIAV	SPATA31D1	446	Q6ZQQ2
QSMNILTSVLLLYTK	TBC1D8	591	O95759
QAMNIVTSVLLLYAK	TBC1D9	601	Q6ZT07
YSNSIKEMVILFATT	UBR1	1286	Q8IWV7
KLNSSIQYVLEVTSM	PKHD1L1	1321	Q86WI1
SLITKQMLTFYSADT	UPK1A	126	O00322
YLNKVMSSLFLDTSV	PKD2L2	56	Q9NZM6
TLLFLIMTTKNSNIY	SLC14A1	346	Q13336
SSLNSNVYDVAMKLV	VCPIP1	616	Q96JH7
YISFNKTMTQLSSTL	PKD2L1	456	Q9P0L9
NSISKLTQLTQSSMY	TPGS2	96	Q68CL5
YTTIELFSMSLNAKT	SNRNP200	1826	O75643
KYNSALDTNATMINS	ZHX2	266	Q9Y6X8
QTKTLAESALQMLYA	TLN2	1766	Q9Y4G6
AMNSLYLATISLKIV	TRPC5	441	Q9UL62
YNVTVIISKNMLSLL	PIEZO1	1221	Q92508
LICMNTSTSYISKQL	VEGFD	151	O43915
TLALSDSQMKSYQSF	GTF3C1	1436	Q12789
NMSQLTTLILSYNAL	SLIT1	806	O75093
SKSLNYLLMSASQTK	ZFYVE26	1031	Q68DK2
MNSLYLATISLKIVA	TRPC4	441	Q9UBN4
KMVVAQQLASALSYL	TYK2	711	P29597
LSIINSMAQSYAKRI	VMP1	381	Q96GC9
IEMATKLYRTTLSQT	MYO1B	1071	O43795
RILTTCYMASKNSSQ	NADSYN1	411	Q6IA69
SSQLMLDTKYLFQVT	MYO5C	1701	Q9NQX4
LTSYVQQLLSAMNKQ	MYO7B	2091	Q6PIF6
AVTVRNSMAKSLYSA	MYO9A	491	B2RTY4